(+)-pilocarpine increases expression EXP 6480464 Pilocarpine results in increased expression of CTNNB1 protein CTD PMID:12387456 (+)-sesamin increases expression ISO RGD:733705 6480464 sesamin results in increased expression of CTNNB1 mRNA, sesamin results in increased expression of CTNNB1 protein CTD PMID:33561518 (-)-demecolcine increases expression ISO RGD:733705 6480464 Demecolcine results in increased expression of CTNNB1 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate decreases expression ISO RGD:733705 6480464 epigallocatechin gallate results in decreased expression of CTNNB1 mRNA, epigallocatechin gallate results in decreased expression of CTNNB1 protein CTD PMID:16968065 (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 epigallocatechin gallate promotes the reaction [Sulindac inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of CTNNB1 protein]] CTD PMID:29999212 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1550466 6480464 epigallocatechin gallate inhibits the reaction [Diethylnitrosamine results in increased expression of CTNNB1 mRNA], epigallocatechin gallate inhibits the reaction [Diethylnitrosamine results in increased expression of CTNNB1 protein] CTD PMID:27058323 (-)-epigallocatechin 3-gallate decreases expression ISO RGD:1550466 6480464 epigallocatechin gallate results in decreased expression of CTNNB1 protein CTD PMID:12351151 (-)-epigallocatechin 3-gallate decreases localization ISO RGD:733705 6480464 epigallocatechin gallate results in decreased localization of CTNNB1 protein CTD PMID:16968065 (-)-epigallocatechin 3-gallate decreases phosphorylation ISO RGD:733705 6480464 epigallocatechin gallate results in decreased phosphorylation of CTNNB1 protein CTD PMID:16968065 (25R)-cholest-5-ene-3beta,26-diol increases activity ISO RGD:733705 6480464 27-hydroxycholesterol results in increased activity of CTNNB1 protein CTD PMID:33131013 (25R)-cholest-5-ene-3beta,26-diol multiple interactions ISO RGD:733705 6480464 27-hydroxycholesterol inhibits the reaction [CTNNB1 protein binds to GSK3B protein] more ... CTD PMID:33131013 (R)-adrenaline multiple interactions EXP 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Epinephrine results in increased phosphorylation of CTNNB1 protein], Niclosamide inhibits the reaction [Epinephrine results in increased phosphorylation of CTNNB1 protein] CTD PMID:26964897 (R)-adrenaline increases phosphorylation EXP 6480464 Epinephrine results in increased phosphorylation of CTNNB1 protein CTD PMID:26964897 (S)-nicotine multiple interactions ISO RGD:1550466 6480464 Nicotine promotes the reaction [Carbon Tetrachloride results in increased expression of CTNNB1 mRNA], Nicotine promotes the reaction [Carbon Tetrachloride results in increased expression of CTNNB1 protein] CTD PMID:33640489 (S)-nicotine increases expression ISO RGD:1550466 6480464 Nicotine results in increased expression of CTNNB1 mRNA, Nicotine results in increased expression of CTNNB1 protein CTD PMID:33640489 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression ISO RGD:733705 6480464 o, p'-DDT results in decreased expression of CTNNB1 mRNA CTD PMID:26225806 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane increases expression ISO RGD:733705 6480464 2, 2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of CTNNB1 mRNA CTD PMID:16580782 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane increases activity ISO RGD:733705 6480464 2, 2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased activity of CTNNB1 protein CTD PMID:19238344 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane multiple interactions ISO RGD:733705 6480464 CDH2 protein affects the reaction [2 more ... CTD PMID:16580782 , PMID:19238344 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of CTNNB1 protein CTD PMID:29031619 , PMID:29999212 1,2-dimethylhydrazine multiple interactions ISO RGD:1550466 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CTNNB1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:1550466 6480464 1, 2-Dimethylhydrazine results in decreased expression of CTNNB1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of CTNNB1 mRNA CTD PMID:32387197 1,2-dimethylhydrazine multiple interactions EXP 6480464 [chlorophyllin affects the reaction [1 more ... CTD PMID:12628520 more ... 1,2-dimethylhydrazine increases mutagenesis EXP 6480464 1, 2-Dimethylhydrazine results in increased mutagenesis of CTNNB1 gene CTD PMID:12628520 1,3-dinitrobenzene increases expression EXP 6480464 3-dinitrobenzene results in increased expression of CTNNB1 mRNA CTD PMID:24140754 1-(4-methoxybenzyl)-3-(5-nitro-1,3-thiazol-2-yl)urea multiple interactions ISO RGD:733705 6480464 N-(4-methoxybenzyl)-N'-(5-nitro-1, 3-thiazol-2-yl)urea inhibits the reaction [Arsenic Trioxide results in decreased expression of CTNNB1 protein] CTD PMID:32305283 17alpha-ethynylestradiol multiple interactions ISO RGD:1550466 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CTNNB1 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:733705 6480464 [Arsenic co-treated with Estradiol] results in decreased expression of CTNNB1 mRNA more ... CTD PMID:16053526 more ... 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with bisphenol A] results in decreased expression of CTNNB1 mRNA more ... CTD PMID:17170212 more ... 17beta-estradiol affects localization EXP 6480464 Estradiol affects the localization of CTNNB1 protein CTD PMID:17170212 17beta-estradiol increases expression ISO RGD:1550466 6480464 Estradiol results in increased expression of CTNNB1 mRNA CTD PMID:14648872 17beta-estradiol multiple interactions ISO RGD:1550466 6480464 [Bromocriptine co-treated with Estradiol] results in decreased expression of CTNNB1 protein, Estradiol results in increased expression of and affects the localization of CTNNB1 protein CTD PMID:11786374 , PMID:23684557 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one multiple interactions ISO RGD:733705 6480464 Metribolone promotes the reaction [NDRG1 protein binds to CTNNB1 protein] CTD PMID:17220478 2,2',4,4',5,5'-hexachlorobiphenyl increases degradation EXP 6480464 2 more ... CTD PMID:19464575 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 2 more ... CTD PMID:19464575 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:733705 6480464 2 more ... CTD PMID:31675489 2,3,4,7,8-Pentachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:21724226 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1550466 6480464 Tetrachlorodibenzodioxin affects the expression of CTNNB1 mRNA CTD PMID:21570461 , PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CTNNB1 protein CTD PMID:24231000 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733705 6480464 Tetrachlorodibenzodioxin results in increased expression of CTNNB1 mRNA, Tetrachlorodibenzodioxin results in increased expression of CTNNB1 protein CTD PMID:22902829 , PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:733705 6480464 Tetrachlorodibenzodioxin results in decreased expression of CTNNB1 protein CTD PMID:22134133 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733705 6480464 CTNNB1 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA], Lithium Chloride inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CTNNB1 protein] CTD PMID:22134133 , PMID:34403729 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin binds to and results in increased activity of AHR protein] which results in decreased expression of CTNNB1 protein more ... CTD PMID:21602191 , PMID:24231000 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1550466 6480464 Tetrachlorodibenzodioxin results in increased expression of CTNNB1 mRNA CTD PMID:17586704 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1550466 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CTNNB1 mRNA more ... CTD PMID:17942748 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases activity ISO RGD:1550466 6480464 Tetrachlorodibenzodioxin results in decreased activity of CTNNB1 protein CTD PMID:24928892 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:21724226 2,3-bis(4-hydroxyphenyl)propionitrile multiple interactions EXP 6480464 2, 3-bis(4-hydroxyphenyl)-propionitrile inhibits the reaction [Estrogens deficiency results in decreased expression of CTNNB1 mRNA] CTD PMID:30565903 2,4,6-trinitrobenzenesulfonic acid multiple interactions EXP 6480464 geraniol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CTNNB1 mRNA] more ... CTD PMID:26165751 2,4,6-trinitrobenzenesulfonic acid increases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in increased expression of CTNNB1 mRNA, Trinitrobenzenesulfonic Acid results in increased expression of CTNNB1 protein CTD PMID:26165751 2,6-di-tert-butyl-4-methylphenol multiple interactions ISO RGD:1550466 6480464 [Butylated Hydroxytoluene co-treated with Oxygen] affects the localization of CTNNB1 protein, [Butylated Hydroxytoluene co-treated with Oxygen] results in increased expression of CTNNB1 protein CTD PMID:16272459 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of CTNNB1 mRNA CTD PMID:21346803 2-hydroxypropanoic acid increases expression ISO RGD:733705 6480464 Lactic Acid results in increased expression of CTNNB1 mRNA CTD PMID:30851411 2-methoxy-17beta-estradiol multiple interactions ISO RGD:733705 6480464 2-Methoxyestradiol inhibits the reaction [CTNNB1 protein results in decreased susceptibility to Bortezomib] CTD PMID:18485479 2-methoxy-17beta-estradiol decreases expression ISO RGD:733705 6480464 2-Methoxyestradiol results in decreased expression of CTNNB1 mRNA, 2-Methoxyestradiol results in decreased expression of CTNNB1 protein CTD PMID:18485479 2-nitrotoluene increases mutagenesis ISO RGD:1550466 6480464 2-nitrotoluene results in increased mutagenesis of CTNNB1 gene CTD PMID:13678655 26-hydroxycholesterol multiple interactions ISO RGD:733705 6480464 27-hydroxycholesterol inhibits the reaction [CTNNB1 protein binds to GSK3B protein] more ... CTD PMID:33131013 26-hydroxycholesterol increases activity ISO RGD:733705 6480464 27-hydroxycholesterol results in increased activity of CTNNB1 protein CTD PMID:33131013 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine decreases expression EXP 6480464 Puromycin Aminonucleoside results in decreased expression of CTNNB1 protein CTD PMID:12065681 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1550466 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of CTNNB1 mRNA CTD PMID:20188158 3,5-dichloro-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-hydroxy-6-methoxybenzamide multiple interactions EXP 6480464 DRD2 protein affects the reaction [Raclopride results in increased expression of CTNNB1 protein] CTD PMID:16144542 3,5-dichloro-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-hydroxy-6-methoxybenzamide increases expression EXP 6480464 Raclopride results in increased expression of CTNNB1 protein CTD PMID:16144542 3,5-diethoxycarbonyl-1,4-dihydrocollidine decreases expression ISO RGD:1550466 6480464 3 more ... CTD PMID:23620592 3,5-diethoxycarbonyl-1,4-dihydrocollidine multiple interactions ISO RGD:1550466 6480464 CTNNB1 mutant form inhibits the reaction [3 more ... CTD PMID:23620592 3,5-diethoxycarbonyl-1,4-dihydrocollidine decreases response to substance ISO RGD:1550466 6480464 CTNNB1 protein results in decreased susceptibility to 3 more ... CTD PMID:23620592 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid multiple interactions ISO RGD:733705 6480464 [MK-886 binds to and results in decreased activity of PPARA protein] inhibits the reaction [perfluorooctanoic acid results in decreased expression of CTNNB1 protein] CTD PMID:23978332 3-aminobenzamide decreases expression ISO RGD:733705 6480464 3-aminobenzamide results in decreased expression of CTNNB1 mRNA CTD PMID:15670817 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:733705 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CTNNB1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CTNNB1 mRNA CTD PMID:28628672 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of CTNNB1 protein] CTD PMID:29535048 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1550466 6480464 [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased expression of CTNNB1 protein more ... CTD PMID:28285642 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine increases mutagenesis EXP 6480464 2-amino-3-methylimidazo(4, 5-f)quinoline results in increased mutagenesis of CTNNB1 gene CTD PMID:12628520 , PMID:9515794 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine multiple interactions EXP 6480464 [chlorophyllin affects the reaction [2-amino-3-methylimidazo(4 more ... CTD PMID:12628520 3-methylcholanthrene multiple interactions ISO RGD:1550466 6480464 CTNNB1 gene mutant form affects the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA] more ... CTD PMID:21498875 , PMID:25174530 3-methylcholanthrene affects response to substance ISO RGD:1550466 6480464 CTNNB1 protein affects the susceptibility to Methylcholanthrene CTD PMID:21498875 3-methylcholanthrene increases response to substance ISO RGD:1550466 6480464 CTNNB1 protein results in increased susceptibility to Methylcholanthrene CTD PMID:25174530 3-Nitrobenzanthrone decreases expression ISO RGD:733705 6480464 3-nitrobenzanthrone results in decreased expression of CTNNB1 mRNA CTD PMID:34036453 4,4'-diaminodiphenylmethane increases expression ISO RGD:1550466 6480464 4, 4'-diaminodiphenylmethane results in increased expression of CTNNB1 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions ISO RGD:733705 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CTNNB1 mRNA CTD PMID:28628672 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions ISO RGD:733705 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of and affects the localization of CTNNB1 protein more ... CTD PMID:28321046 4-hydroxynon-2-enal decreases expression ISO RGD:733705 6480464 4-hydroxy-2-nonenal results in decreased expression of CTNNB1 mRNA, 4-hydroxy-2-nonenal results in decreased expression of CTNNB1 protein CTD PMID:12419474 , PMID:24825450 4-methylthio-2-oxobutanoic acid decreases expression ISO RGD:733705 6480464 2-keto-4-methylthiobutyric acid results in decreased expression of CTNNB1 protein CTD PMID:28414304 4-methylthio-2-oxobutanoic acid decreases expression ISO RGD:1550466 6480464 2-keto-4-methylthiobutyric acid results in decreased expression of CTNNB1 protein CTD PMID:28414304 5-aza-2'-deoxycytidine multiple interactions ISO RGD:733705 6480464 5-furan-2yl-isoxazole-3-carboxylic acid (3-imidazol-1yl-propyl)-amide inhibits the reaction [Decitabine affects the localization of CTNNB1 protein], Decitabine inhibits the reaction [bisphenol A results in decreased expression of CTNNB1 protein] CTD PMID:30125549 , PMID:30303745 5-aza-2'-deoxycytidine increases expression ISO RGD:733705 6480464 Decitabine results in increased expression of CTNNB1 protein CTD PMID:19234609 5-aza-2'-deoxycytidine decreases response to substance ISO RGD:733705 6480464 CTNNB1 protein results in decreased susceptibility to Decitabine CTD PMID:19234609 5-aza-2'-deoxycytidine decreases expression ISO RGD:1550466 6480464 Decitabine results in decreased expression of CTNNB1 mRNA CTD PMID:19222872 5-aza-2'-deoxycytidine affects localization ISO RGD:733705 6480464 Decitabine affects the localization of CTNNB1 protein CTD PMID:19387464 , PMID:30125549 5-aza-2'-deoxycytidine decreases localization ISO RGD:733705 6480464 Decitabine results in decreased localization of CTNNB1 protein CTD PMID:21515334 5-formyltetrahydrofolic acid multiple interactions EXP 6480464 [Methotrexate co-treated with Leucovorin] results in increased expression of CTNNB1 protein CTD PMID:25187349 5-methoxypsoralen multiple interactions ISO RGD:1550466 6480464 5-Methoxypsoralen inhibits the reaction [Streptozocin results in increased phosphorylation of CTNNB1 protein] CTD PMID:34428446 6-bromoindirubin-3'-oxime multiple interactions ISO RGD:733705 6480464 [6-bromoindirubin-3'-oxime co-treated with DHFR mRNA] affects the expression of CTNNB1 protein more ... CTD PMID:19727391 , PMID:31163223 6-bromoindirubin-3'-oxime increases expression ISO RGD:733705 6480464 6-bromoindirubin-3'-oxime results in increased expression of CTNNB1 protein CTD PMID:18624906 , PMID:26259606 6-bromoindirubin-3'-oxime decreases phosphorylation ISO RGD:733705 6480464 6-bromoindirubin-3'-oxime results in decreased phosphorylation of CTNNB1 protein CTD PMID:19727391 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CTNNB1 mRNA CTD PMID:24780913 7,12-dimethyltetraphene increases expression ISO RGD:733705 6480464 9 more ... CTD PMID:29663660 7,12-dimethyltetraphene multiple interactions ISO RGD:733705 6480464 9 more ... CTD PMID:29663660 [6]-Shogaol decreases expression ISO RGD:733705 6480464 shogaol results in decreased expression of CTNNB1 mRNA, shogaol results in decreased expression of CTNNB1 protein CTD PMID:27645308 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of CTNNB1 mRNA CTD PMID:31881176 acetylleucyl-leucyl-norleucinal multiple interactions ISO RGD:733705 6480464 acetylleucyl-leucyl-norleucinal inhibits the reaction [Immunologic Factors results in decreased expression of CTNNB1 protein] CTD PMID:29974605 acetylsalicylic acid decreases localization ISO RGD:733705 6480464 Aspirin results in decreased localization of CTNNB1 protein CTD PMID:16878161 , PMID:17357503 acetylsalicylic acid multiple interactions ISO RGD:733705 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Aspirin results in increased ubiquitination of CTNNB1 protein] more ... CTD PMID:12813129 , PMID:16878161 acetylsalicylic acid increases ubiquitination ISO RGD:733705 6480464 Aspirin results in increased ubiquitination of CTNNB1 protein CTD PMID:16878161 acetylsalicylic acid increases phosphorylation ISO RGD:733705 6480464 Aspirin results in increased phosphorylation of CTNNB1 protein CTD PMID:12813129 , PMID:16878161 acrolein increases expression ISO RGD:733705 6480464 Acrolein results in increased expression of CTNNB1 protein CTD PMID:20525806 acrolein multiple interactions ISO RGD:733705 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of and affects the oxidation of CTNNB1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of and affects the oxidation of CTNNB1 mRNA CTD PMID:32699268 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of CTNNB1 mRNA CTD PMID:28959563 Aeroplysinin 1 decreases expression ISO RGD:733705 6480464 aeroplysinin I results in decreased expression of CTNNB1 protein CTD PMID:27120392 AH23848 multiple interactions ISO RGD:733705 6480464 [6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] promotes the reaction [AXIN1 protein binds to CTNNB1 protein] more ... CTD PMID:19407222 AICA ribonucleotide increases expression ISO RGD:1550466 6480464 AICA ribonucleotide results in increased expression of CTNNB1 mRNA, AICA ribonucleotide results in increased expression of CTNNB1 protein CTD PMID:21454484 AICA ribonucleotide multiple interactions ISO RGD:1550466 6480464 [AICA ribonucleotide results in increased phosphorylation of HDAC5 protein] which results in increased expression of CTNNB1 mRNA more ... CTD PMID:21454484 aldehydo-D-glucose multiple interactions EXP 6480464 Simvastatin inhibits the reaction [Glucose results in decreased expression of CTNNB1 protein] CTD PMID:18004065 aldehydo-D-glucose multiple interactions ISO RGD:733705 6480464 DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 mRNA], DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 protein] CTD PMID:29163160 aldehydo-D-glucose increases expression ISO RGD:733705 6480464 Glucose results in increased expression of CTNNB1 mRNA, Glucose results in increased expression of CTNNB1 protein CTD PMID:29163160 aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of CTNNB1 mRNA, Glucose results in decreased expression of CTNNB1 protein CTD PMID:18004065 , PMID:21818840 all-trans-retinoic acid multiple interactions ISO RGD:1550466 6480464 [Cholecalciferol co-treated with Tretinoin] affects the localization of CTNNB1 protein, Tretinoin inhibits the reaction [Cholecalciferol results in increased expression of CTNNB1 mRNA] CTD PMID:17170073 all-trans-retinoic acid multiple interactions ISO RGD:733705 6480464 Arsenic Trioxide promotes the reaction [Tretinoin results in decreased expression of CTNNB1 protein], Tretinoin promotes the reaction [Arsenic Trioxide results in decreased expression of CTNNB1 protein] CTD PMID:30093655 all-trans-retinoic acid decreases expression ISO RGD:733705 6480464 Tretinoin results in decreased expression of CTNNB1 mRNA, Tretinoin results in decreased expression of CTNNB1 protein CTD PMID:21924320 , PMID:30093655 all-trans-retinoic acid decreases expression ISO RGD:1550466 6480464 Tretinoin results in decreased expression of CTNNB1 protein CTD PMID:17064353 all-trans-retinoic acid increases expression ISO RGD:1550466 6480464 Tretinoin results in increased expression of CTNNB1 mRNA CTD PMID:16236135 all-trans-retinoic acid increases expression ISO RGD:733705 6480464 Tretinoin results in increased expression of CTNNB1 mRNA, Tretinoin results in increased expression of CTNNB1 protein CTD PMID:17219422 , PMID:33167477 all-trans-retinol multiple interactions ISO RGD:733705 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Vitamin A results in decreased expression of CTNNB1 protein] more ... CTD PMID:17219422 all-trans-retinol decreases expression ISO RGD:733705 6480464 Vitamin A results in decreased expression of CTNNB1 protein CTD PMID:17219422 alpha-pinene multiple interactions ISO RGD:733705 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of and affects the oxidation of CTNNB1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of and affects the oxidation of CTNNB1 mRNA CTD PMID:32699268 ammonia affects metabolic processing ISO RGD:1550466 6480464 CTNNB1 protein affects the metabolism of Ammonia CTD PMID:16557553 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CTNNB1 mRNA CTD PMID:16483693 ammonium chloride increases expression EXP 6480464 Ammonium Chloride results in increased expression of CTNNB1 protein CTD PMID:16483693 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of CTNNB1 protein CTD PMID:16144542 arecoline multiple interactions ISO RGD:1550466 6480464 [Arecoline co-treated with 4-nitroquinolone-1-oxide] results in increased expression of CTNNB1 protein CTD PMID:26464283 aristolochic acid multiple interactions ISO RGD:733705 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in decreased expression of CTNNB1 protein, BMP7 protein inhibits the reaction [[aristolochic acid I co-treated with aristolochic acid II] results in increased expression of CTNNB1 protein] CTD PMID:25663515 Aroclor 1254 decreases expression ISO RGD:1550466 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of CTNNB1 mRNA CTD PMID:23650126 arsane multiple interactions ISO RGD:733705 6480464 [Arsenic co-treated with Estradiol] results in decreased expression of CTNNB1 mRNA more ... CTD PMID:22552367 , PMID:33047385 arsane increases expression ISO RGD:733705 6480464 Arsenic results in increased expression of CTNNB1 mRNA CTD PMID:29107899 arsane increases expression ISO RGD:1550466 6480464 Arsenic results in increased expression of CTNNB1 protein CTD PMID:22552367 arsenic atom multiple interactions ISO RGD:733705 6480464 [Arsenic co-treated with Estradiol] results in decreased expression of CTNNB1 mRNA more ... CTD PMID:22552367 , PMID:33047385 arsenic atom increases expression ISO RGD:733705 6480464 Arsenic results in increased expression of CTNNB1 mRNA CTD PMID:29107899 arsenic atom increases expression ISO RGD:1550466 6480464 Arsenic results in increased expression of CTNNB1 protein CTD PMID:22552367 arsenic trichloride increases expression ISO RGD:733705 6480464 arsenic trichloride results in increased expression of CTNNB1 protein CTD PMID:21854796 arsenic trichloride multiple interactions ISO RGD:733705 6480464 CAT protein inhibits the reaction [arsenic trichloride results in increased activity of CTNNB1 protein], CAT protein inhibits the reaction [arsenic trichloride results in increased expression of CTNNB1 protein] CTD PMID:21854796 arsenic trichloride increases activity ISO RGD:733705 6480464 arsenic trichloride results in increased activity of CTNNB1 protein CTD PMID:21854796 arsenite(3-) affects localization ISO RGD:733705 6480464 arsenite affects the localization of CTNNB1 protein CTD PMID:17400267 arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of CTNNB1 protein CTD PMID:21344382 arsenite(3-) multiple interactions ISO RGD:733705 6480464 arsenite inhibits the reaction [G3BP1 protein binds to CTNNB1 mRNA], RTKI cpd inhibits the reaction [arsenite affects the localization of CTNNB1 protein] CTD PMID:17400267 , PMID:32406909 arsenite(3-) decreases phosphorylation ISO RGD:733705 6480464 arsenite results in decreased phosphorylation of CTNNB1 protein CTD PMID:17400267 arsenous acid multiple interactions ISO RGD:733705 6480464 [Arsenic Trioxide binds to PIN1 protein] affects the reaction [Arsenic Trioxide results in decreased expression of CTNNB1 protein] more ... CTD PMID:18485479 more ... arsenous acid increases cleavage ISO RGD:733705 6480464 Arsenic Trioxide results in increased cleavage of CTNNB1 protein CTD PMID:12181429 arsenous acid decreases expression ISO RGD:733705 6480464 Arsenic Trioxide results in decreased expression of CTNNB1 mRNA, Arsenic Trioxide results in decreased expression of CTNNB1 protein CTD PMID:17512576 more ... arsenous acid increases expression ISO RGD:733705 6480464 Arsenic Trioxide results in increased expression of CTNNB1 mRNA CTD PMID:20458559 artesunate multiple interactions EXP 6480464 artesunate inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of CTNNB1 protein] CTD PMID:29031619 atazanavir sulfate multiple interactions ISO RGD:733705 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of CTNNB1 mRNA CTD PMID:33819548 atropine multiple interactions ISO RGD:733705 6480464 Atropine inhibits the reaction [Parathion results in increased expression of CTNNB1 protein mutant form], Atropine inhibits the reaction [Parathion results in increased expression of CTNNB1 protein] CTD PMID:17390078 auraptene decreases expression EXP 6480464 aurapten results in decreased expression of CTNNB1 protein mutant form CTD PMID:16012713 benzene multiple interactions ISO RGD:1550466 6480464 Benzene results in increased expression of and results in decreased phosphorylation of CTNNB1 protein, PPP2R1A protein affects the reaction [Benzene results in increased expression of and results in decreased phosphorylation of CTNNB1 protein] CTD PMID:30567741 benzo[a]pyrene increases expression ISO RGD:1550466 6480464 Benzo(a)pyrene results in increased expression of CTNNB1 mRNA CTD PMID:22228805 benzo[a]pyrene increases expression ISO RGD:733705 6480464 Benzo(a)pyrene metabolite results in increased expression of CTNNB1 mRNA, Benzo(a)pyrene results in increased expression of CTNNB1 mRNA CTD PMID:21714911 , PMID:26314263 berberine increases expression ISO RGD:733705 6480464 Berberine results in increased expression of CTNNB1 protein CTD PMID:26478571 berberine multiple interactions ISO RGD:733705 6480464 CTNNB1 mutant form inhibits the reaction [Berberine results in increased expression of BGLAP protein] more ... CTD PMID:26478571 beta-naphthoflavone multiple interactions ISO RGD:1550466 6480464 CTNNB1 gene mutant form affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA], CTNNB1 gene mutant form inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 mRNA] CTD PMID:25174530 betulin multiple interactions ISO RGD:733705 6480464 [betulin co-treated with Oxygen deficiency] results in decreased expression of CTNNB1 protein CTD PMID:33181113 betulinic acid decreases expression ISO RGD:733705 6480464 betulinic acid results in decreased expression of CTNNB1 protein CTD PMID:30136359 betulinic acid multiple interactions ISO RGD:733705 6480464 [betulinic acid co-treated with Erlotinib Hydrochloride] results in decreased expression of CTNNB1 protein, [betulinic acid co-treated with Oxygen deficiency] results in decreased expression of CTNNB1 protein CTD PMID:30136359 , PMID:33181113 bis(2-ethylhexyl) phthalate affects localization ISO RGD:1550466 6480464 Diethylhexyl Phthalate affects the localization of CTNNB1 protein CTD PMID:20307648 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of and affects the localization of CTNNB1 protein], Diethylhexyl Phthalate results in increased expression of and affects the localization of CTNNB1 protein CTD PMID:29940330 bis(2-ethylhexyl) phthalate increases expression ISO RGD:733705 6480464 Diethylhexyl Phthalate results in increased expression of CTNNB1 protein CTD PMID:30944277 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1550466 6480464 Diethylhexyl Phthalate results in increased expression of CTNNB1 mRNA CTD PMID:26219507 , PMID:27495896 bisphenol A decreases expression ISO RGD:733705 6480464 bisphenol A results in decreased expression of CTNNB1 protein CTD PMID:26922907 more ... bisphenol A increases expression ISO RGD:1550466 6480464 bisphenol A results in increased expression of CTNNB1 mRNA, bisphenol A results in increased expression of CTNNB1 protein CTD PMID:33221593 , PMID:33802611 bisphenol A increases expression ISO RGD:733705 6480464 bisphenol A results in increased expression of CTNNB1 mRNA, bisphenol A results in increased expression of CTNNB1 protein CTD PMID:33024228 , PMID:34602561 bisphenol A affects localization ISO RGD:733705 6480464 bisphenol A affects the localization of CTNNB1 protein CTD PMID:32360864 bisphenol A affects expression ISO RGD:733705 6480464 bisphenol A affects the expression of CTNNB1 mRNA CTD PMID:30903817 bisphenol A decreases methylation ISO RGD:1550466 6480464 bisphenol A results in decreased methylation of CTNNB1 promoter CTD PMID:27312807 bisphenol A multiple interactions ISO RGD:733705 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of CTNNB1 gene more ... CTD PMID:24532171 more ... bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CTNNB1 mRNA, bisphenol A results in decreased expression of CTNNB1 protein CTD PMID:19497385 more ... bisphenol A multiple interactions EXP 6480464 [Estradiol co-treated with bisphenol A] results in decreased expression of CTNNB1 mRNA more ... CTD PMID:25381574 more ... bisphenol A affects localization EXP 6480464 bisphenol A affects the localization of CTNNB1 protein CTD PMID:25381574 bisphenol A affects localization ISO RGD:1550466 6480464 bisphenol A affects the localization of CTNNB1 protein CTD PMID:26063408 bisphenol A decreases expression ISO RGD:1550466 6480464 bisphenol A results in decreased expression of CTNNB1 mRNA, bisphenol A results in decreased expression of CTNNB1 protein CTD PMID:23900028 more ... bisphenol F multiple interactions ISO RGD:733705 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CTNNB1 mRNA CTD PMID:28628672 boric acid multiple interactions ISO RGD:1550466 6480464 boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased expression of CTNNB1 protein] more ... CTD PMID:28285642 bortezomib multiple interactions ISO RGD:733705 6480464 2-methoxyestradiol inhibits the reaction [CTNNB1 protein results in decreased susceptibility to Bortezomib] more ... CTD PMID:18485479 , PMID:19100720 bortezomib decreases response to substance ISO RGD:733705 6480464 CTNNB1 protein results in decreased susceptibility to Bortezomib CTD PMID:18485479 bortezomib increases expression ISO RGD:733705 6480464 Bortezomib results in increased expression of CTNNB1 protein CTD PMID:18485479 , PMID:19100720 bosutinib affects localization ISO RGD:733705 6480464 bosutinib affects the localization of CTNNB1 protein CTD PMID:16489032 bosutinib decreases phosphorylation ISO RGD:733705 6480464 bosutinib results in decreased phosphorylation of CTNNB1 protein CTD PMID:16489032 bosutinib multiple interactions ISO RGD:733705 6480464 bosutinib inhibits the reaction [CTNNB1 protein binds to TCF4 protein] more ... CTD PMID:16489032 brazilein decreases expression ISO RGD:733705 6480464 brazilein results in decreased expression of CTNNB1 protein CTD PMID:23948132 bromocriptine multiple interactions ISO RGD:1550466 6480464 [Bromocriptine co-treated with Estradiol] results in decreased expression of CTNNB1 protein CTD PMID:11786374 bucladesine increases phosphorylation EXP 6480464 Bucladesine results in increased phosphorylation of CTNNB1 protein CTD PMID:26964897 butylated hydroxyanisole multiple interactions ISO RGD:1550466 6480464 CTNNB1 gene mutant form inhibits the reaction [Butylated Hydroxyanisole results in increased expression of CYP1A1 mRNA], CTNNB1 gene mutant form inhibits the reaction [Butylated Hydroxyanisole results in increased expression of CYP1A2 mRNA] CTD PMID:25174530 Butylbenzyl phthalate multiple interactions ISO RGD:733705 6480464 HDAC6 mutant form inhibits the reaction [butylbenzyl phthalate affects the localization of CTNNB1 protein], trichostatin A inhibits the reaction [butylbenzyl phthalate affects the localization of CTNNB1 protein] CTD PMID:22552774 Butylbenzyl phthalate increases acetylation ISO RGD:1550466 6480464 butylbenzyl phthalate results in increased acetylation of CTNNB1 protein CTD PMID:27923775 Butylbenzyl phthalate affects localization ISO RGD:733705 6480464 butylbenzyl phthalate affects the localization of CTNNB1 protein CTD PMID:22552774 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of CTNNB1 mRNA CTD PMID:19167457 cadmium atom multiple interactions ISO RGD:733705 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cadmium results in increased expression of and results in increased activity of CTNNB1 protein] more ... CTD PMID:22884995 more ... cadmium atom increases activity ISO RGD:733705 6480464 Cadmium results in increased activity of CTNNB1 protein CTD PMID:22884995 cadmium atom affects localization ISO RGD:733705 6480464 Cadmium affects the localization of CTNNB1 protein CTD PMID:24798214 cadmium atom affects localization EXP 6480464 Cadmium affects the localization of CTNNB1 protein CTD PMID:23080431 cadmium dichloride affects localization EXP 6480464 Cadmium Chloride affects the localization of CTNNB1 protein CTD PMID:20459685 cadmium dichloride multiple interactions ISO RGD:733705 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CTNNB1 protein, ARL6 protein inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CTNNB1 protein] CTD PMID:32522577 cadmium dichloride increases expression ISO RGD:733705 6480464 Cadmium Chloride results in increased expression of CTNNB1 mRNA, Cadmium Chloride results in increased expression of CTNNB1 protein CTD PMID:26472689 , PMID:28527916 cadmium dichloride affects localization ISO RGD:733705 6480464 Cadmium Chloride affects the localization of CTNNB1 protein CTD PMID:24532171 cadmium dichloride multiple interactions ISO RGD:1550466 6480464 Cadmium Chloride results in increased phosphorylation of and affects the localization of CTNNB1 protein CTD PMID:19818801 cadmium dichloride decreases activity ISO RGD:1550466 6480464 Cadmium Chloride results in decreased activity of CTNNB1 protein CTD PMID:19818801 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of CTNNB1 protein CTD PMID:15618353 cadmium dichloride affects expression ISO RGD:1550466 6480464 Cadmium Chloride affects the expression of CTNNB1 mRNA CTD PMID:18974090 cadmium dichloride multiple interactions EXP 6480464 Cadmium Chloride inhibits the reaction [CTNNB1 protein binds to CDH1 protein binds to CTNNA1 protein] more ... CTD PMID:15618353 more ... caffeine increases mutagenesis EXP 6480464 Caffeine results in increased mutagenesis of CTNNB1 gene CTD PMID:18283038 caffeine multiple interactions EXP 6480464 Caffeine inhibits the reaction [Doxorubicin results in decreased expression of CTNNB1 protein] CTD PMID:30377735 calciol multiple interactions ISO RGD:1550466 6480464 [Cholecalciferol co-treated with Tretinoin] affects the localization of CTNNB1 protein more ... CTD PMID:17170073 calciol increases expression ISO RGD:1550466 6480464 Cholecalciferol results in increased expression of CTNNB1 mRNA CTD PMID:17170073 calcitriol multiple interactions ISO RGD:733705 6480464 [Calcitriol binds to VDR protein] which results in decreased activity of CTNNB1 mRNA more ... CTD PMID:16051482 , PMID:20043299 calcitriol decreases activity ISO RGD:733705 6480464 Calcitriol results in decreased activity of CTNNB1 protein CTD PMID:16051482 calcium atom increases expression ISO RGD:733705 6480464 Calcium results in increased expression of CTNNB1 mRNA, Calcium results in increased expression of CTNNB1 protein CTD PMID:24658506 calcium atom multiple interactions ISO RGD:733705 6480464 CTNNB1 mutant form inhibits the reaction [Calcium results in increased expression of KRT1 mRNA] more ... CTD PMID:24658506 calcium(0) multiple interactions ISO RGD:733705 6480464 CTNNB1 mutant form inhibits the reaction [Calcium results in increased expression of KRT1 mRNA] more ... CTD PMID:24658506 calcium(0) increases expression ISO RGD:733705 6480464 Calcium results in increased expression of CTNNB1 mRNA, Calcium results in increased expression of CTNNB1 protein CTD PMID:24658506 calyculin a increases phosphorylation ISO RGD:733705 6480464 calyculin A results in increased phosphorylation of CTNNB1 protein CTD PMID:12813129 , PMID:16878161 cannabidiol decreases phosphorylation ISO RGD:733705 6480464 Cannabidiol results in decreased phosphorylation of CTNNB1 protein CTD PMID:32060308 cannabidiol multiple interactions ISO RGD:733705 6480464 [Cannabidiol co-treated with SB 203580] results in decreased phosphorylation of CTNNB1 protein, Cannabidiol promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of CTNNB1 protein] CTD PMID:32060308 capsaicin increases expression EXP 6480464 Capsaicin results in increased expression of CTNNB1 protein CTD PMID:22150557 capsaicin multiple interactions EXP 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CTNNB1 protein] more ... CTD PMID:22150557 carbamazepine affects expression ISO RGD:733705 6480464 Carbamazepine affects the expression of CTNNB1 mRNA CTD PMID:24752500 celastrol decreases expression ISO RGD:733705 6480464 celastrol results in decreased expression of CTNNB1 protein CTD PMID:31715269 celastrol multiple interactions ISO RGD:733705 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [celastrol results in decreased expression of CTNNB1 protein] more ... CTD PMID:31715269 celastrol multiple interactions ISO RGD:1550466 6480464 celastrol affects the reaction [APC protein mutant form affects the expression of CTNNB1 protein], celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of CTNNB1 protein] CTD PMID:31715269 celecoxib affects localization ISO RGD:733705 6480464 Celecoxib affects the localization of CTNNB1 protein, Celecoxib analog affects the localization of CTNNB1 protein CTD PMID:19682443 CGS-21680 affects localization ISO RGD:733705 6480464 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine affects the localization of CTNNB1 protein modified form CTD PMID:27595240 CGS-21680 multiple interactions ISO RGD:733705 6480464 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine results in increased expression of and affects the phosphorylation of CTNNB1 protein, CTNNB1 protein affects the reaction [2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine results in increased expression of COL3A1 protein] CTD PMID:27595240 chenodeoxycholic acid multiple interactions ISO RGD:733705 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CTNNB1 mRNA, [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of CTNNB1 mRNA CTD PMID:33819548 CHIR 99021 increases expression ISO RGD:733705 6480464 Chir 99021 results in increased expression of CTNNB1 protein CTD PMID:26259606 CHIR 99021 affects localization ISO RGD:1550466 6480464 Chir 99021 affects the localization of CTNNB1 protein CTD PMID:32220932 CHIR 99021 multiple interactions ISO RGD:733705 6480464 Chir 99021 affects the reaction [NAMPT protein affects the expression of CTNNB1 protein], Chir 99021 inhibits the reaction [celastrol results in decreased expression of CTNNB1 protein] CTD PMID:31715269 , PMID:32005247 chitosan multiple interactions EXP 6480464 [Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of CTNNB1 protein] CTD PMID:28732690 chlordecone decreases expression ISO RGD:733705 6480464 Chlordecone results in decreased expression of CTNNB1 protein CTD PMID:11695219 chlorohydrocarbon increases expression ISO RGD:733705 6480464 Hydrocarbons, Chlorinated analog results in increased expression of CTNNB1 protein CTD PMID:24355586 chloroquine multiple interactions EXP 6480464 Chloroquine inhibits the reaction [Dibutyl Phthalate results in increased expression of CTNNB1 mRNA] CTD PMID:30053495 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of CTNNB1 mRNA CTD PMID:20691718 chlorpyrifos affects expression ISO RGD:733705 6480464 Chlorpyrifos affects the expression of CTNNB1 protein CTD PMID:33930485 , PMID:34424684 chlorpyrifos multiple interactions ISO RGD:733705 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide affects the reaction [Chlorpyrifos affects the expression of CTNNB1 protein] more ... CTD PMID:32956863 , PMID:34424684 chromium(6+) multiple interactions ISO RGD:733705 6480464 CAT protein inhibits the reaction [chromium hexavalent ion results in increased expression of and results in increased activity of CTNNB1 protein] more ... CTD PMID:22552367 , PMID:27323401 chromium(6+) increases activity ISO RGD:733705 6480464 chromium hexavalent ion results in increased activity of CTNNB1 protein CTD PMID:27323401 chromium(6+) decreases expression ISO RGD:733705 6480464 chromium hexavalent ion results in decreased expression of CTNNB1 protein CTD PMID:23518002 chromium(6+) increases expression ISO RGD:1550466 6480464 chromium hexavalent ion results in increased expression of CTNNB1 protein CTD PMID:22552367 chrysin multiple interactions ISO RGD:733705 6480464 chrysin inhibits the reaction [Topotecan results in increased cleavage of CTNNB1 protein] CTD PMID:20457140 chrysin 5,7-dimethyl ether multiple interactions EXP 6480464 5 more ... CTD PMID:21554863 cisplatin decreases expression ISO RGD:1550466 6480464 Cisplatin results in decreased expression of CTNNB1 mRNA, Cisplatin results in decreased expression of CTNNB1 protein CTD PMID:23628706 more ... cisplatin decreases expression ISO RGD:733705 150530284 Cisplatin decreases expression of CTNNB1 mRNA and protein in lung RGD cisplatin multiple interactions ISO RGD:733705 6480464 [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of CTNNB1 mRNA, [NEAT1 protein affects the susceptibility to Cisplatin] which affects the expression of and affects the phosphorylation of CTNNB1 protein CTD PMID:30291867 , PMID:30871063 cisplatin multiple interactions EXP 6480464 wogonin inhibits the reaction [Cisplatin results in increased expression of CTNNB1 protein] CTD PMID:31103702 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of CTNNB1 protein CTD PMID:31103702 cisplatin decreases response to substance ISO RGD:1550466 6480464 CTNNB1 protein results in decreased susceptibility to Cisplatin CTD PMID:24560772 cisplatin increases phosphorylation ISO RGD:1550466 6480464 Cisplatin results in increased phosphorylation of CTNNB1 protein CTD PMID:24560772 cisplatin increases expression ISO RGD:733705 6480464 Cisplatin results in increased expression of CTNNB1 protein CTD PMID:20074550 cisplatin decreases localization ISO RGD:1550466 6480464 Cisplatin results in decreased localization of CTNNB1 protein CTD PMID:21745194 cisplatin multiple interactions ISO RGD:1550466 6480464 8-(4-chloro-phenylthio)-2'-O-methyladenosine-3'-5'-cyclic monophosphate inhibits the reaction [Cisplatin results in decreased localization of CTNNB1 protein] more ... CTD PMID:21745194 more ... cisplatin decreases response to substance ISO RGD:733705 6480464 CTNNB1 results in decreased susceptibility to Cisplatin CTD PMID:22000491 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of CTNNB1 mRNA CTD PMID:17602206 clozapine increases expression EXP 6480464 Clozapine results in increased expression of CTNNB1 protein CTD PMID:16144542 clozapine multiple interactions EXP 6480464 DRD2 protein affects the reaction [Clozapine results in increased expression of CTNNB1 protein] CTD PMID:16144542 cobalt dichloride decreases expression ISO RGD:733705 6480464 cobaltous chloride results in decreased expression of CTNNB1 mRNA CTD PMID:19320972 cobalt dichloride increases expression ISO RGD:733705 6480464 cobaltous chloride results in increased expression of CTNNB1 mRNA CTD PMID:17553155 , PMID:26314263 cocaine affects expression EXP 6480464 Cocaine affects the expression of CTNNB1 mRNA CTD PMID:20187946 cocaine multiple interactions EXP 6480464 Cocaine deficiency promotes the reaction [SMARCA4 protein binds to CTNNB1 promoter] CTD PMID:27422367 coenzyme Q10 multiple interactions ISO RGD:1550466 6480464 coenzyme Q10 inhibits the reaction [Acetaminophen affects the phosphorylation of and affects the localization of CTNNB1 protein] CTD PMID:34668565 corosolic acid increases degradation ISO RGD:733705 6480464 corosolic acid results in increased degradation of CTNNB1 protein CTD PMID:24566423 corticosterone multiple interactions ISO RGD:1550466 6480464 [Corticosterone results in increased phosphorylation of NDRG1 protein] promotes the reaction [NDRG1 protein binds to CTNNB1 protein], [Corticosterone results in increased phosphorylation of NDRG1 protein] which results in increased expression of and results in increased localization of CTNNB1 protein CTD PMID:21655274 cortisol increases localization ISO RGD:733705 6480464 Hydrocortisone results in increased localization of CTNNB1 protein CTD PMID:25763180 cortisol multiple interactions ISO RGD:733705 6480464 GGTI 298 inhibits the reaction [Hydrocortisone results in increased localization of CTNNB1 protein] CTD PMID:25763180 coumarin decreases expression ISO RGD:733705 6480464 coumarin analog results in decreased expression of CTNNB1 mRNA CTD PMID:32578917 crocidolite asbestos affects expression ISO RGD:733705 6480464 Asbestos more ... CTD PMID:17331233 , PMID:21570478 crocidolite asbestos multiple interactions ISO RGD:733705 6480464 Asbestos more ... CTD PMID:24160326 Cryptotanshinone multiple interactions ISO RGD:733705 6480464 cryptotanshinone inhibits the reaction [Dinoprostone results in increased expression of CTNNB1 protein] CTD PMID:30208247 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of CTNNB1 mRNA CTD PMID:26577399 curcumin decreases expression ISO RGD:733705 6480464 Curcumin analog results in decreased expression of CTNNB1 mRNA more ... CTD PMID:17041101 more ... curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [bisphenol A results in decreased expression of CTNNB1 mRNA], Curcumin results in decreased phosphorylation of and affects the localization of CTNNB1 protein CTD PMID:25963729 curcumin decreases phosphorylation EXP 6480464 Curcumin results in decreased phosphorylation of CTNNB1 protein CTD PMID:25963729 curcumin increases expression EXP 6480464 Curcumin results in increased expression of CTNNB1 mRNA CTD PMID:25963729 curcumin decreases expression ISO RGD:1550466 6480464 Curcumin results in decreased expression of CTNNB1 protein CTD PMID:10783313 curcumin multiple interactions ISO RGD:733705 6480464 [piperine co-treated with Curcumin] results in decreased expression of CTNNB1 protein more ... CTD PMID:19294764 more ... curcumin increases degradation ISO RGD:733705 6480464 Curcumin analog results in increased degradation of CTNNB1 protein, Curcumin results in increased degradation of CTNNB1 protein CTD PMID:17041101 cycloheximide decreases expression ISO RGD:1550466 6480464 Cycloheximide results in decreased expression of CTNNB1 protein CTD PMID:27693619 cycloheximide multiple interactions ISO RGD:1550466 6480464 Phenobarbital affects the reaction [Cycloheximide results in decreased expression of CTNNB1 protein] CTD PMID:27693619 cyclosporin A decreases expression ISO RGD:1550466 6480464 Cyclosporine results in decreased expression of CTNNB1 protein CTD PMID:22416070 cyclosporin A decreases expression ISO RGD:733705 6480464 Cyclosporine results in decreased expression of CTNNB1 mRNA CTD PMID:20106945 , PMID:25562108 D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of CTNNB1 mRNA, Glucose results in decreased expression of CTNNB1 protein CTD PMID:18004065 , PMID:21818840 D-glucose multiple interactions ISO RGD:733705 6480464 DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 mRNA], DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 protein] CTD PMID:29163160 D-glucose increases expression ISO RGD:733705 6480464 Glucose results in increased expression of CTNNB1 mRNA, Glucose results in increased expression of CTNNB1 protein CTD PMID:29163160 D-glucose multiple interactions EXP 6480464 Simvastatin inhibits the reaction [Glucose results in decreased expression of CTNNB1 protein] CTD PMID:18004065 DDE increases activity ISO RGD:733705 6480464 Dichlorodiphenyl Dichloroethylene results in increased activity of CTNNB1 protein CTD PMID:27589886 DDE affects activity ISO RGD:733705 6480464 Dichlorodiphenyl Dichloroethylene affects the activity of CTNNB1 protein CTD PMID:25386960 DDE multiple interactions ISO RGD:733705 6480464 CTNNB1 affects the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of CCND1 protein], CTNNB1 affects the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of MYC protein] CTD PMID:25386960 DDT multiple interactions ISO RGD:733705 6480464 Acetylcysteine inhibits the reaction [DDT results in increased expression of and results in decreased phosphorylation of CTNNB1 protein] more ... CTD PMID:22902829 , PMID:24968063 DDT affects localization ISO RGD:733705 6480464 DDT affects the localization of CTNNB1 protein CTD PMID:24968063 DDT increases expression ISO RGD:733705 6480464 DDT results in increased expression of CTNNB1 protein CTD PMID:22902829 deguelin decreases expression ISO RGD:733705 6480464 deguelin results in decreased expression of CTNNB1 mRNA, deguelin results in decreased expression of CTNNB1 protein CTD PMID:21472727 , PMID:33512557 deguelin increases degradation ISO RGD:733705 6480464 deguelin results in increased degradation of CTNNB1 protein CTD PMID:21472727 deguelin multiple interactions ISO RGD:733705 6480464 [deguelin results in increased degradation of CTNNB1 protein] which results in decreased expression of CCND1 protein more ... CTD PMID:21472727 , PMID:22986522 delta-tocotrienol decreases expression ISO RGD:733705 6480464 tocotrienol, delta results in decreased expression of CTNNB1 protein CTD PMID:21453743 deoxycholic acid multiple interactions ISO RGD:733705 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CTNNB1 mRNA, [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of CTNNB1 mRNA CTD PMID:33819548 deoxynivalenol affects phosphorylation ISO RGD:1550466 6480464 deoxynivalenol affects the phosphorylation of CTNNB1 protein CTD PMID:23811945 desferrioxamine B multiple interactions ISO RGD:733705 6480464 [Oxygen deficiency co-treated with Paclitaxel co-treated with FV-429 compound co-treated with Deferoxamine] affects the localization of CTNNB1 protein, Deferoxamine inhibits the reaction [ferumoxides results in increased activity of CTNNB1 protein] CTD PMID:20338187 , PMID:34648812 Destruxin B affects localization ISO RGD:733705 6480464 destruxin B affects the localization of CTNNB1 protein CTD PMID:22465936 Destruxin B multiple interactions ISO RGD:733705 6480464 destruxin B results in decreased activity of [TCF4 protein co-treated with CTNNB1 protein], Sorafenib promotes the reaction [destruxin B results in decreased expression of CTNNB1 protein] CTD PMID:22465936 , PMID:24434019 Destruxin B decreases expression ISO RGD:733705 6480464 destruxin B results in decreased expression of CTNNB1 protein, destruxin B results in decreased expression of CTNNB1 protein modified form CTD PMID:22465936 , PMID:24434019 dexamethasone decreases expression ISO RGD:1550466 6480464 Dexamethasone results in decreased expression of CTNNB1 protein CTD PMID:20578217 dexamethasone multiple interactions EXP 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of CTNNB1 protein] more ... CTD PMID:20501703 , PMID:29535048 dexamethasone affects localization EXP 6480464 Dexamethasone affects the localization of CTNNB1 protein CTD PMID:20501703 dexamethasone multiple interactions ISO RGD:733705 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CTNNB1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CTNNB1 mRNA CTD PMID:28628672 dexamethasone multiple interactions ISO RGD:1550466 6480464 [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased expression of CTNNB1 protein more ... CTD PMID:28285642 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of CTNNB1 mRNA, Dexamethasone results in decreased expression of CTNNB1 protein CTD PMID:18467435 , PMID:20501703 dextran sulfate increases expression ISO RGD:1550466 6480464 Dextran Sulfate results in increased expression of CTNNB1 protein CTD PMID:16049979 dextran sulfate multiple interactions ISO RGD:1550466 6480464 [2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:15459021 more ... diallyl disulfide increases expression ISO RGD:733705 6480464 diallyl disulfide results in increased expression of CTNNB1 mRNA, diallyl disulfide results in increased expression of CTNNB1 protein CTD PMID:20600798 diallyl disulfide decreases phosphorylation ISO RGD:733705 6480464 diallyl disulfide results in decreased phosphorylation of CTNNB1 protein CTD PMID:23663050 diallyl trisulfide increases cleavage ISO RGD:733705 6480464 diallyl trisulfide results in increased cleavage of CTNNB1 protein CTD PMID:22578287 diallyl trisulfide decreases expression ISO RGD:733705 6480464 diallyl trisulfide results in decreased expression of CTNNB1 protein CTD PMID:29626521 diallyl trisulfide multiple interactions ISO RGD:733705 6480464 diallyl trisulfide inhibits the reaction [CTNNB1 protein results in decreased expression of CDKN1A protein] more ... CTD PMID:29626521 diallyl trisulfide decreases phosphorylation ISO RGD:733705 6480464 diallyl trisulfide results in decreased phosphorylation of CTNNB1 protein CTD PMID:23663050 diarsenic trioxide multiple interactions ISO RGD:733705 6480464 [Arsenic Trioxide binds to PIN1 protein] affects the reaction [Arsenic Trioxide results in decreased expression of CTNNB1 protein] more ... CTD PMID:18485479 more ... diarsenic trioxide decreases expression ISO RGD:733705 6480464 Arsenic Trioxide results in decreased expression of CTNNB1 mRNA, Arsenic Trioxide results in decreased expression of CTNNB1 protein CTD PMID:17512576 more ... diarsenic trioxide increases expression ISO RGD:733705 6480464 Arsenic Trioxide results in increased expression of CTNNB1 mRNA CTD PMID:20458559 diarsenic trioxide increases cleavage ISO RGD:733705 6480464 Arsenic Trioxide results in increased cleavage of CTNNB1 protein CTD PMID:12181429 diazoxide multiple interactions ISO RGD:733705 6480464 Diazoxide inhibits the reaction [CTNNB1 protein results in increased activity of CCND1 promoter] CTD PMID:19052819 diazoxide decreases expression ISO RGD:733705 6480464 Diazoxide results in decreased expression of CTNNB1 protein CTD PMID:19052819 dibutyl phthalate affects localization ISO RGD:733705 6480464 Dibutyl Phthalate affects the localization of CTNNB1 protein CTD PMID:22552774 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of CTNNB1 mRNA, Dibutyl Phthalate results in increased expression of CTNNB1 protein CTD PMID:30053495 dibutyl phthalate multiple interactions EXP 6480464 Chloroquine inhibits the reaction [Dibutyl Phthalate results in increased expression of CTNNB1 mRNA], Sirolimus promotes the reaction [Dibutyl Phthalate results in increased expression of CTNNB1 mRNA] CTD PMID:30053495 dibutyl phthalate multiple interactions ISO RGD:733705 6480464 HDAC6 mutant form inhibits the reaction [Dibutyl Phthalate affects the localization of CTNNB1 protein], trichostatin A inhibits the reaction [Dibutyl Phthalate affects the localization of CTNNB1 protein] CTD PMID:22552774 dichloromethane increases mutagenesis ISO RGD:1550466 6480464 Methylene Chloride results in increased mutagenesis of CTNNB1 gene CTD PMID:10467420 diclofenac affects expression ISO RGD:733705 6480464 Diclofenac affects the expression of CTNNB1 mRNA CTD PMID:24752500 dicrotophos decreases expression ISO RGD:733705 6480464 dicrotophos results in decreased expression of CTNNB1 mRNA CTD PMID:28302478 diethylstilbestrol increases expression ISO RGD:1550466 6480464 Diethylstilbestrol results in increased expression of CTNNB1 mRNA CTD PMID:14648872 diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of CTNNB1 protein CTD PMID:26911934 dimethyl sulfoxide increases expression ISO RGD:733705 6480464 Dimethyl Sulfoxide results in increased expression of CTNNB1 protein CTD PMID:20091315 dioscin increases expression ISO RGD:1550466 6480464 dioscin results in increased expression of CTNNB1 mRNA, dioscin results in increased expression of CTNNB1 protein CTD PMID:24742230 dioscin multiple interactions ISO RGD:1550466 6480464 fulvestrant inhibits the reaction [dioscin results in increased expression of CTNNB1 mRNA] CTD PMID:24742230 dioscin increases expression ISO RGD:733705 6480464 dioscin results in increased expression of CTNNB1 protein CTD PMID:24742230 diosgenin decreases expression ISO RGD:1550466 6480464 Diosgenin results in decreased expression of CTNNB1 mRNA CTD PMID:26408789 dioxygen multiple interactions ISO RGD:1550466 6480464 [Butylated Hydroxytoluene co-treated with Oxygen] affects the localization of CTNNB1 protein, [Butylated Hydroxytoluene co-treated with Oxygen] results in increased expression of CTNNB1 protein CTD PMID:16272459 dioxygen increases expression ISO RGD:733705 6480464 Oxygen deficiency results in increased expression of CTNNB1 protein CTD PMID:34648812 dioxygen affects localization ISO RGD:733705 6480464 Oxygen deficiency affects the localization of CTNNB1 protein CTD PMID:25297617 dioxygen multiple interactions ISO RGD:733705 6480464 [amurensin G results in decreased activity of SIRT1 protein] inhibits the reaction [Oxygen deficiency results in decreased expression of CTNNB1] more ... CTD PMID:22245592 more ... dioxygen decreases acetylation ISO RGD:733705 6480464 Oxygen deficiency results in decreased acetylation of CTNNB1 protein CTD PMID:22245592 dioxygen decreases expression ISO RGD:733705 6480464 Oxygen deficiency results in decreased expression of CTNNB1 mRNA CTD PMID:17175027 disodium cromoglycate multiple interactions EXP 6480464 [Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of CTNNB1 protein] CTD PMID:28732690 diuron increases expression EXP 6480464 Diuron results in increased expression of CTNNB1 mRNA CTD PMID:21551480 dizocilpine maleate decreases expression ISO RGD:733705 6480464 Dizocilpine Maleate results in decreased expression of CTNNB1 mRNA CTD PMID:31563592 dizocilpine maleate multiple interactions ISO RGD:733705 6480464 Famotidine inhibits the reaction [Dizocilpine Maleate results in decreased expression of CTNNB1 mRNA], Olanzapine inhibits the reaction [Dizocilpine Maleate results in decreased expression of CTNNB1 mRNA] CTD PMID:31563592 dorsomorphin multiple interactions ISO RGD:733705 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases response to substance ISO RGD:1550466 6480464 CTNNB1 gene mutant form results in decreased susceptibility to Doxorubicin CTD PMID:20237062 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of CTNNB1 protein CTD PMID:30377735 doxorubicin multiple interactions EXP 6480464 Caffeine inhibits the reaction [Doxorubicin results in decreased expression of CTNNB1 protein] more ... CTD PMID:30377735 doxorubicin increases expression ISO RGD:733705 6480464 Doxorubicin results in increased expression of CTNNB1 mRNA CTD PMID:29803840 doxorubicin multiple interactions ISO RGD:733705 6480464 [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 protein] inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein] more ... CTD PMID:19047049 , PMID:32886829 doxorubicin decreases phosphorylation ISO RGD:733705 6480464 Doxorubicin results in decreased phosphorylation of CTNNB1 protein CTD PMID:23956100 doxorubicin increases expression ISO RGD:1550466 6480464 Doxorubicin results in increased expression of CTNNB1 protein CTD PMID:20237062 eckol decreases expression ISO RGD:733705 6480464 eckol results in decreased expression of CTNNB1 protein CTD PMID:21514314 endosulfan multiple interactions ISO RGD:733705 6480464 Endosulfan inhibits the reaction [CDH1 protein binds to CTNNB1 protein], Endosulfan results in increased expression of and affects the localization of CTNNB1 protein CTD PMID:22677888 , PMID:22902829 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of CTNNB1 protein CTD PMID:26911934 endosulfan decreases expression ISO RGD:733705 6480464 Endosulfan results in decreased expression of CTNNB1 protein CTD PMID:28108160 erlotinib hydrochloride multiple interactions ISO RGD:733705 6480464 [betulinic acid co-treated with Erlotinib Hydrochloride] results in decreased expression of CTNNB1 protein CTD PMID:30136359 erlotinib hydrochloride affects phosphorylation ISO RGD:733705 6480464 Erlotinib Hydrochloride affects the phosphorylation of CTNNB1 protein CTD PMID:34463000 erlotinib hydrochloride decreases expression ISO RGD:733705 6480464 Erlotinib Hydrochloride results in decreased expression of CTNNB1 protein CTD PMID:30136359 Estradiol dipropionate multiple interactions ISO RGD:1550466 6480464 [estradiol dipropionate co-treated with Butyrates] results in decreased expression of CTNNB1 protein, [estradiol dipropionate co-treated with trichostatin A] results in decreased expression of CTNNB1 protein CTD PMID:15930180 ethanol multiple interactions ISO RGD:733705 6480464 Ethanol results in increased expression of and affects the localization of CTNNB1 protein more ... CTD PMID:26014148 , PMID:30567741 ethanol multiple interactions ISO RGD:1550466 6480464 Ethanol affects the expression of and affects the splicing of CTNNB1 mRNA CTD PMID:30319688 ethanol multiple interactions EXP 6480464 Ethanol affects the reaction [Dietary Fats affects the expression of CTNNB1 mRNA], Ethanol affects the reaction [Dietary Fats affects the expression of CTNNB1 protein] CTD PMID:31811911 ethanol affects localization ISO RGD:733705 6480464 Ethanol affects the localization of CTNNB1 protein CTD PMID:30567741 ethanol affects response to substance ISO RGD:733705 6480464 CTNNB1 gene mutant form affects the susceptibility to Ethanol CTD PMID:25822088 ethosuximide multiple interactions EXP 6480464 Ethosuximide inhibits the reaction [APP protein modified form results in decreased expression of CTNNB1 mRNA] CTD PMID:26420483 ethosuximide increases expression EXP 6480464 Ethosuximide results in increased expression of CTNNB1 mRNA CTD PMID:26420483 ethosuximide decreases phosphorylation EXP 6480464 Ethosuximide results in decreased phosphorylation of CTNNB1 protein CTD PMID:26420483 ethosuximide multiple interactions ISO RGD:733705 6480464 DKK1 protein inhibits the reaction [Ethosuximide results in decreased phosphorylation of CTNNB1 protein] CTD PMID:26420483 etoposide multiple interactions ISO RGD:733705 6480464 [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 protein] inhibits the reaction [Etoposide results in increased activity of CASP3 protein] more ... CTD PMID:19047049 eugenol decreases expression ISO RGD:1550466 6480464 Eugenol results in decreased expression of CTNNB1 mRNA CTD PMID:31926151 eugenol decreases expression ISO RGD:733705 6480464 Eugenol results in decreased expression of CTNNB1 mRNA CTD PMID:31926151 eugenol multiple interactions ISO RGD:1550466 6480464 Eugenol results in decreased expression of and affects the phosphorylation of and affects the localization of CTNNB1 protein CTD PMID:31926151 eugenol multiple interactions ISO RGD:733705 6480464 Eugenol results in decreased expression of and affects the phosphorylation of and affects the localization of CTNNB1 protein CTD PMID:31926151 famotidine multiple interactions ISO RGD:733705 6480464 Famotidine inhibits the reaction [Dizocilpine Maleate results in decreased expression of CTNNB1 mRNA] CTD PMID:31563592 famotidine increases expression ISO RGD:733705 6480464 Famotidine results in increased expression of CTNNB1 mRNA CTD PMID:31563592 febuxostat multiple interactions EXP 6480464 Febuxostat inhibits the reaction [Paraquat results in increased expression of CTNNB1 protein] CTD PMID:30726711 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of CTNNB1 mRNA CTD PMID:34044035 fisetin decreases expression ISO RGD:733705 6480464 fisetin results in decreased expression of CTNNB1 protein CTD PMID:30802432 fisetin multiple interactions ISO RGD:733705 6480464 fisetin inhibits the reaction [Tobacco Smoke Pollution results in increased expression of CTNNB1 protein] CTD PMID:31606474 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of CTNNB1 mRNA CTD PMID:23238999 flavonoids multiple interactions EXP 6480464 DKK1 protein inhibits the reaction [Flavonoids results in increased expression of CTNNB1 mRNA] CTD PMID:23238999 fluoxetine multiple interactions EXP 6480464 [Fluoxetine co-treated with Ketanserin] results in increased expression of CTNNB1 mRNA, Fluoxetine inhibits the reaction [Monocrotaline results in decreased expression of CTNNB1 protein] CTD PMID:21619414 , PMID:21627639 flutamide affects localization ISO RGD:733705 6480464 Flutamide analog affects the localization of CTNNB1 protein CTD PMID:21111724 folic acid affects expression ISO RGD:733705 6480464 Folic Acid affects the expression of CTNNB1 mRNA CTD PMID:16361273 folic acid decreases expression ISO RGD:733705 6480464 Folic Acid deficiency results in decreased expression of CTNNB1 protein CTD PMID:28639913 folic acid multiple interactions ISO RGD:1550466 6480464 [1 more ... CTD PMID:22206623 , PMID:22959928 formaldehyde decreases expression ISO RGD:733705 6480464 Formaldehyde results in decreased expression of CTNNB1 mRNA CTD PMID:23649840 fulvestrant multiple interactions ISO RGD:733705 6480464 [AG 1879 co-treated with Fulvestrant] inhibits the reaction [Chlorpyrifos results in decreased expression of and affects the localization of CTNNB1 protein] more ... CTD PMID:31601247 , PMID:32956863 fulvestrant multiple interactions ISO RGD:1550466 6480464 fulvestrant inhibits the reaction [dioscin results in increased expression of CTNNB1 mRNA] CTD PMID:24742230 fumonisin B1 increases expression ISO RGD:1550466 6480464 fumonisin B1 results in increased expression of CTNNB1 mRNA CTD PMID:16221962 geldanamycin multiple interactions ISO RGD:733705 6480464 geldanamycin promotes the reaction [CDH1 protein binds to CTNNB1 protein], IL24 protein promotes the reaction [geldanamycin promotes the reaction [CDH1 protein binds to CTNNB1 protein]] CTD PMID:17024233 gemcitabine increases expression ISO RGD:733705 6480464 gemcitabine results in increased expression of CTNNB1 mRNA CTD PMID:25605917 genistein multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in increased expression of CTNNB1 protein CTD PMID:16443925 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CTNNB1 mRNA CTD PMID:22061828 geraniol multiple interactions EXP 6480464 geraniol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CTNNB1 mRNA] more ... CTD PMID:26165751 , PMID:28428697 gingerol affects localization ISO RGD:733705 6480464 gingerol affects the localization of CTNNB1 protein CTD PMID:18058799 gingerol increases expression ISO RGD:1550466 6480464 gingerol results in increased expression of CTNNB1 mRNA CTD PMID:26498061 gingerol multiple interactions ISO RGD:1550466 6480464 gingerol results in increased expression of and affects the localization of CTNNB1 protein CTD PMID:26498061 gingerol multiple interactions ISO RGD:733705 6480464 gingerol promotes the reaction [IL1B protein results in increased expression of CTNNB1 protein] CTD PMID:27645308 glucose decreases expression EXP 6480464 Glucose results in decreased expression of CTNNB1 mRNA, Glucose results in decreased expression of CTNNB1 protein CTD PMID:18004065 , PMID:21818840 glucose increases expression ISO RGD:733705 6480464 Glucose results in increased expression of CTNNB1 mRNA, Glucose results in increased expression of CTNNB1 protein CTD PMID:29163160 glucose multiple interactions ISO RGD:733705 6480464 DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 mRNA], DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 protein] CTD PMID:29163160 glucose multiple interactions EXP 6480464 Simvastatin inhibits the reaction [Glucose results in decreased expression of CTNNB1 protein] CTD PMID:18004065 glycochenodeoxycholic acid multiple interactions ISO RGD:733705 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CTNNB1 mRNA, [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of CTNNB1 mRNA CTD PMID:33819548 glycocholic acid multiple interactions ISO RGD:733705 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CTNNB1 mRNA, [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of CTNNB1 mRNA CTD PMID:33819548 glycodeoxycholic acid multiple interactions ISO RGD:733705 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CTNNB1 mRNA, [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of CTNNB1 mRNA CTD PMID:33819548 glyphosate increases expression EXP 6480464 glyphosate results in increased expression of CTNNB1 protein CTD PMID:28780397 glyphosate decreases expression ISO RGD:733705 6480464 glyphosate results in decreased expression of CTNNB1 mRNA CTD PMID:31295307 haloperidol multiple interactions EXP 6480464 DRD2 protein affects the reaction [Haloperidol results in increased expression of CTNNB1 protein] CTD PMID:16144542 haloperidol decreases expression ISO RGD:1550466 6480464 Haloperidol results in decreased expression of CTNNB1 mRNA CTD PMID:18797397 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of CTNNB1 protein CTD PMID:16144542 heparin multiple interactions EXP 6480464 Heparin promotes the reaction [Doxorubicin results in decreased expression of CTNNB1 protein], Lithium Chloride inhibits the reaction [Heparin promotes the reaction [Doxorubicin results in decreased expression of CTNNB1 protein]] CTD PMID:30377735 heptachlor multiple interactions ISO RGD:733705 6480464 Heptachlor inhibits the reaction [CDH1 protein binds to CTNNB1 protein] CTD PMID:22902829 heptachlor increases expression ISO RGD:733705 6480464 Heptachlor results in increased expression of CTNNB1 protein CTD PMID:22902829 hexachlorophene multiple interactions ISO RGD:733705 6480464 Hexachlorophene inhibits the reaction [Lithium Chloride results in increased expression of CTNNB1 protein] more ... CTD PMID:16735606 hexachlorophene increases degradation ISO RGD:733705 6480464 Hexachlorophene results in increased degradation of CTNNB1 protein CTD PMID:16735606 hyaluronic acid multiple interactions ISO RGD:733705 6480464 [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 protein] inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein] more ... CTD PMID:19047049 hydrogen cyanide decreases expression ISO RGD:1550466 6480464 Hydrogen Cyanide results in decreased expression of CTNNB1 mRNA CTD PMID:33914522 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of CTNNB1 protein CTD PMID:16204253 hydrogen peroxide multiple interactions ISO RGD:733705 6480464 Hydrogen Peroxide inhibits the reaction [CDH5 protein binds to CTNNB1 protein], naringin inhibits the reaction [Hydrogen Peroxide results in decreased expression of CTNNB1 protein] CTD PMID:24211779 , PMID:26482937 hydrogen peroxide multiple interactions EXP 6480464 pirinixic acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of CTNNB1 protein], pirinixic acid inhibits the reaction [Hydrogen Peroxide results in decreased stability of CTNNB1 protein] CTD PMID:16204253 hydrogen peroxide decreases expression ISO RGD:733705 6480464 Hydrogen Peroxide results in decreased expression of CTNNB1 mRNA, Hydrogen Peroxide results in decreased expression of CTNNB1 protein CTD PMID:12419474 , PMID:26482937 hydrogen sulfide multiple interactions ISO RGD:1550466 6480464 [Hydrogen Sulfide results in increased abundance of sodium sulfide] which results in decreased expression of CTNNB1 mRNA more ... CTD PMID:33068716 hydroquinone decreases expression ISO RGD:733705 6480464 hydroquinone results in decreased expression of CTNNB1 protein CTD PMID:28886972 hydroquinone affects localization ISO RGD:733705 6480464 hydroquinone affects the localization of CTNNB1 protein CTD PMID:30567741 hydroquinone multiple interactions ISO RGD:733705 6480464 hydroquinone inhibits the reaction [CTNNB1 protein binds to LEF1 protein] more ... CTD PMID:28886972 , PMID:30567741 hydroxyflutamide decreases phosphorylation ISO RGD:733705 6480464 hydroxyflutamide results in decreased phosphorylation of CTNNB1 protein CTD PMID:28163245 hydroxyflutamide multiple interactions ISO RGD:733705 6480464 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3 more ... CTD PMID:28163245 indometacin affects localization ISO RGD:733705 6480464 Indomethacin affects the localization of CTNNB1 protein CTD PMID:15963497 indometacin increases expression EXP 6480464 Indomethacin results in increased expression of CTNNB1 protein CTD PMID:16818512 indometacin multiple interactions EXP 6480464 1-(4-chlorobenzoyl)-5-methoxy-2-1H-indole-3-acetic acid 3-(nitrooxymethyl)phenyl ester inhibits the reaction [Indomethacin results in increased expression of CTNNB1 protein], nitroaspirin inhibits the reaction [Indomethacin results in increased expression of CTNNB1 protein] CTD PMID:16818512 indometacin increases phosphorylation ISO RGD:733705 6480464 Indomethacin results in increased phosphorylation of CTNNB1 protein CTD PMID:12813129 indometacin decreases expression ISO RGD:733705 6480464 Indomethacin results in decreased expression of CTNNB1 mRNA, Indomethacin results in decreased expression of CTNNB1 protein CTD PMID:11756231 more ... indometacin multiple interactions ISO RGD:733705 6480464 [Indomethacin co-treated with juglone] results in decreased expression of CTNNB1 mRNA more ... CTD PMID:11756231 more ... isoorientin decreases expression ISO RGD:733705 6480464 homoorientin results in decreased expression of CTNNB1 protein CTD PMID:34019859 ivermectin decreases expression ISO RGD:733705 6480464 Ivermectin results in decreased expression of CTNNB1 protein CTD PMID:32959892 juglone multiple interactions ISO RGD:733705 6480464 [Indomethacin co-treated with juglone] results in decreased expression of CTNNB1 mRNA, [Indomethacin co-treated with juglone] results in decreased expression of CTNNB1 protein CTD PMID:31916655 juglone decreases expression ISO RGD:733705 6480464 juglone results in decreased expression of CTNNB1 mRNA, juglone results in decreased expression of CTNNB1 protein CTD PMID:31916655 kaempferol multiple interactions EXP 6480464 kaempferol promotes the reaction [Sulindac inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of CTNNB1 protein]] CTD PMID:29999212 kenpaullone affects localization ISO RGD:733705 6480464 kenpaullone analog affects the localization of CTNNB1 protein CTD PMID:21111724 ketanserin multiple interactions EXP 6480464 [Fluoxetine co-treated with Ketanserin] results in increased expression of CTNNB1 mRNA CTD PMID:21627639 L-ascorbic acid multiple interactions EXP 6480464 [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of and affects the localization of CTNNB1 protein], [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of CTNNB1 protein] CTD PMID:29940330 lactacystin multiple interactions ISO RGD:733705 6480464 lactacystin inhibits the reaction [Indomethacin results in decreased expression of CTNNB1 protein], lactacystin inhibits the reaction [resveratrol results in increased degradation of CTNNB1 protein] CTD PMID:11756231 , PMID:26040106 lead diacetate increases phosphorylation EXP 6480464 lead acetate results in increased phosphorylation of CTNNB1 protein CTD PMID:24999626 lead diacetate multiple interactions ISO RGD:733705 6480464 WNT7A protein inhibits the reaction [lead acetate results in increased phosphorylation of CTNNB1 protein] CTD PMID:24999626 lead nitrate multiple interactions ISO RGD:1550466 6480464 [lead nitrate results in increased abundance of Lead] which results in decreased expression of and affects the localization of CTNNB1 protein more ... CTD PMID:30731080 lead(0) decreases expression ISO RGD:1550466 6480464 Lead results in decreased expression of CTNNB1 mRNA, Lead results in decreased expression of CTNNB1 protein CTD PMID:23086611 , PMID:26518054 lead(0) multiple interactions ISO RGD:1550466 6480464 [lead nitrate results in increased abundance of Lead] which results in decreased expression of and affects the localization of CTNNB1 protein more ... CTD PMID:30731080 lead(0) decreases expression EXP 6480464 Lead results in decreased expression of CTNNB1 mRNA, Lead results in decreased expression of CTNNB1 protein CTD PMID:23086611 lead(2+) decreases expression ISO RGD:1550466 6480464 Lead results in decreased expression of CTNNB1 mRNA, Lead results in decreased expression of CTNNB1 protein CTD PMID:23086611 , PMID:26518054 lead(2+) multiple interactions ISO RGD:1550466 6480464 [lead nitrate results in increased abundance of Lead] which results in decreased expression of and affects the localization of CTNNB1 protein more ... CTD PMID:30731080 lead(2+) decreases expression EXP 6480464 Lead results in decreased expression of CTNNB1 mRNA, Lead results in decreased expression of CTNNB1 protein CTD PMID:23086611 leupeptin multiple interactions EXP 6480464 leupeptin inhibits the reaction [2 more ... CTD PMID:19464575 LGK974 multiple interactions ISO RGD:733705 6480464 LGK974 inhibits the reaction [Paraquat affects the localization of CTNNB1 protein], LGK974 inhibits the reaction [Paraquat results in increased expression of and results in decreased phosphorylation of CTNNB1 protein] CTD PMID:30205152 lipopolysaccharide increases expression ISO RGD:733705 6480464 Lipopolysaccharides results in increased expression of CTNNB1 protein CTD PMID:11739494 , PMID:32048402 lipopolysaccharide multiple interactions ISO RGD:733705 6480464 HOXA-AS2 inhibits the reaction [Lipopolysaccharides results in increased expression of CTNNB1 protein], MIR106B mRNA inhibits the reaction [HOXA-AS2 inhibits the reaction [Lipopolysaccharides results in increased expression of CTNNB1 protein]] CTD PMID:32048402 lithium atom increases expression ISO RGD:1550466 6480464 Lithium results in increased expression of CTNNB1 protein CTD PMID:19621015 lithium atom increases expression EXP 6480464 Lithium results in increased expression of CTNNB1 protein CTD PMID:12942141 , PMID:18296634 lithium atom decreases expression EXP 6480464 Lithium results in decreased expression of CTNNB1 mRNA CTD PMID:12942141 lithium atom multiple interactions EXP 6480464 Lithium inhibits the reaction [Methamphetamine results in increased expression of CTNNB1 mRNA], Lithium results in increased expression of and affects the localization of CTNNB1 protein CTD PMID:16288908 , PMID:19149911 lithium atom affects localization EXP 6480464 Lithium affects the localization of CTNNB1 protein CTD PMID:18296634 lithium chloride multiple interactions ISO RGD:733705 6480464 [Lithium Chloride co-treated with ESR1 protein] results in increased expression of CTNNB1 protein more ... CTD PMID:12813129 more ... lithium chloride increases expression EXP 6480464 Lithium Chloride results in increased expression of CTNNB1 mRNA CTD PMID:27045591 lithium chloride affects localization ISO RGD:733705 6480464 Lithium Chloride affects the localization of CTNNB1 protein, Lithium Chloride affects the localization of CTNNB1 protein modified form CTD PMID:22493441 more ... lithium chloride increases stability ISO RGD:1550466 6480464 Lithium Chloride results in increased stability of CTNNB1 protein CTD PMID:23326414 lithium chloride increases expression ISO RGD:1550466 6480464 Lithium Chloride results in increased expression of CTNNB1 mRNA, Lithium Chloride results in increased expression of CTNNB1 protein CTD PMID:22935447 more ... lithium chloride increases activity EXP 6480464 Lithium Chloride results in increased activity of CTNNB1 protein CTD PMID:20694829 lithium chloride increases expression ISO RGD:733705 6480464 Lithium Chloride results in increased expression of CTNNB1 mRNA, Lithium Chloride results in increased expression of CTNNB1 protein CTD PMID:16053526 more ... lithium chloride multiple interactions EXP 6480464 [[Lithium Chloride results in decreased activity of GSK3B protein] which results in increased expression of CTNNB1 protein] which affects the expression of GJA1 protein more ... CTD PMID:18972237 more ... lithium chloride increases localization ISO RGD:1550466 6480464 Lithium Chloride results in increased localization of CTNNB1 protein CTD PMID:19442631 lithium chloride increases activity ISO RGD:1550466 6480464 Lithium Chloride results in increased activity of CTNNB1 protein CTD PMID:19582394 , PMID:20118494 lithium chloride multiple interactions ISO RGD:1550466 6480464 [[Lithium Chloride results in increased phosphorylation of and results in decreased activity of GSK3B protein] which results in increased localization of CTNNB1 protein] which results in increased expression of GIP mRNA more ... CTD PMID:15364539 more ... lithium chloride decreases phosphorylation ISO RGD:733705 6480464 Lithium Chloride results in decreased phosphorylation of CTNNB1 protein CTD PMID:16076840 lithium hydride multiple interactions EXP 6480464 Lithium inhibits the reaction [Methamphetamine results in increased expression of CTNNB1 mRNA], Lithium results in increased expression of and affects the localization of CTNNB1 protein CTD PMID:16288908 , PMID:19149911 lithium hydride affects localization EXP 6480464 Lithium affects the localization of CTNNB1 protein CTD PMID:18296634 lithium hydride decreases expression EXP 6480464 Lithium results in decreased expression of CTNNB1 mRNA CTD PMID:12942141 lithium hydride increases expression ISO RGD:1550466 6480464 Lithium results in increased expression of CTNNB1 protein CTD PMID:19621015 lithium hydride increases expression EXP 6480464 Lithium results in increased expression of CTNNB1 protein CTD PMID:12942141 , PMID:18296634 lithocholic acid multiple interactions ISO RGD:733705 6480464 [Lithocholic Acid binds to VDR protein] which results in decreased activity of CTNNB1 mRNA CTD PMID:20043299 losartan multiple interactions ISO RGD:1550466 6480464 Losartan inhibits the reaction [AGT protein affects the localization of CTNNB1 protein] more ... CTD PMID:28578904 losartan multiple interactions ISO RGD:733705 6480464 Losartan inhibits the reaction [AGT protein affects the localization of CTNNB1 protein] more ... CTD PMID:28578904 lovastatin decreases degradation EXP 6480464 Lovastatin results in decreased degradation of CTNNB1 protein CTD PMID:19741129 lovastatin increases expression ISO RGD:1550466 6480464 Lovastatin results in increased expression of CTNNB1 mRNA CTD PMID:24742230 lovastatin multiple interactions ISO RGD:733705 6480464 Lovastatin affects the localization of and results in increased expression of CTNNB1 protein CTD PMID:17234346 lupeol decreases expression ISO RGD:1550466 6480464 lupeol results in decreased expression of CTNNB1 protein CTD PMID:20979057 lupeol multiple interactions ISO RGD:733705 6480464 lupeol results in decreased localization of and results in decreased activity of CTNNB1 protein CTD PMID:20732907 luteolin decreases expression ISO RGD:733705 6480464 Luteolin results in decreased expression of CTNNB1 protein CTD PMID:32268164 LY-2157299 multiple interactions ISO RGD:1550466 6480464 [ABCB4 protein affects the susceptibility to LY-2157299] which affects the expression of CTNNB1 protein CTD PMID:29808285 LY294002 multiple interactions ISO RGD:1550466 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol results in increased stability of CTNNB1 protein] more ... CTD PMID:20542495 more ... LY294002 decreases phosphorylation ISO RGD:733705 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of CTNNB1 protein CTD PMID:32060308 LY294002 decreases expression ISO RGD:1550466 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of CTNNB1 protein CTD PMID:23143138 LY294002 multiple interactions ISO RGD:733705 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cadmium results in increased expression of and results in increased activity of CTNNB1 protein] more ... CTD PMID:19814765 more ... Magnolol multiple interactions EXP 6480464 magnolol inhibits the reaction [Monocrotaline results in increased expression of CTNNB1 protein] CTD PMID:30466619 manganese atom decreases expression ISO RGD:733705 6480464 Manganese results in decreased expression of CTNNB1 mRNA CTD PMID:17175027 manganese(0) decreases expression ISO RGD:733705 6480464 Manganese results in decreased expression of CTNNB1 mRNA CTD PMID:17175027 manganese(II) chloride decreases expression ISO RGD:733705 6480464 manganese chloride results in decreased expression of CTNNB1 mRNA CTD PMID:17175027 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of CTNNB1 protein CTD PMID:24464479 manganese(II) chloride multiple interactions EXP 6480464 Lithium Chloride inhibits the reaction [manganese chloride results in decreased expression of CTNNB1 protein] CTD PMID:24464479 mangiferin decreases response to substance ISO RGD:733705 6480464 CTNNB1 protein results in decreased susceptibility to mangiferin CTD PMID:23707762 Matrine decreases expression ISO RGD:733705 6480464 matrine results in decreased expression of CTNNB1 protein CTD PMID:31112718 MeIQ affects mutagenesis ISO RGD:1550466 6480464 2-amino-3 more ... CTD PMID:12893427 melatonin multiple interactions ISO RGD:733705 6480464 Melatonin inhibits the reaction [Estradiol promotes the reaction [ESR1 protein binds to CTNNB1 promoter]] CTD PMID:26990689 menadione decreases expression ISO RGD:733705 6480464 Vitamin K 3 results in decreased expression of CTNNB1 protein CTD PMID:31238027 metformin decreases expression ISO RGD:733705 6480464 Metformin results in decreased expression of CTNNB1 protein CTD PMID:34432352 methamphetamine multiple interactions EXP 6480464 Lithium inhibits the reaction [Methamphetamine results in increased expression of CTNNB1 mRNA] CTD PMID:19149911 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of CTNNB1 mRNA CTD PMID:19149911 , PMID:32035215 methotrexate multiple interactions ISO RGD:733705 6480464 Methotrexate promotes the reaction [6-bromoindirubin-3'-oxime results in decreased phosphorylation of CTNNB1 protein] CTD PMID:19727391 methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of CTNNB1 protein CTD PMID:25187349 methotrexate multiple interactions EXP 6480464 [Methotrexate co-treated with Leucovorin] results in increased expression of CTNNB1 protein CTD PMID:25187349 methoxychlor multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in increased expression of CTNNB1 protein CTD PMID:16443925 methyl methanesulfonate decreases expression ISO RGD:733705 6480464 Methyl Methanesulfonate results in decreased expression of CTNNB1 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:733705 6480464 methylmercuric chloride results in increased expression of CTNNB1 mRNA CTD PMID:23179753 methylmercury chloride decreases expression ISO RGD:733705 6480464 methylmercuric chloride results in decreased expression of CTNNB1 mRNA CTD PMID:29581082 methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of CTNNB1 protein CTD PMID:28526320 methylmercury(1+) increases expression ISO RGD:733705 6480464 methylmercury II results in increased expression of CTNNB1 mRNA CTD PMID:26314263 microcystin-LR increases ubiquitination ISO RGD:733705 6480464 cyanoginosin LR results in increased ubiquitination of CTNNB1 protein CTD PMID:20421190 mifepristone increases expression ISO RGD:733705 6480464 Mifepristone results in increased expression of CTNNB1 mRNA CTD PMID:17584828 ML-7 decreases expression ISO RGD:733705 6480464 ML 7 results in decreased expression of CTNNB1 protein CTD PMID:18710790 ML-7 affects localization ISO RGD:733705 6480464 ML 7 affects the localization of CTNNB1 protein CTD PMID:18710790 mono(2-ethylhexyl) phthalate increases expression ISO RGD:733705 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of CTNNB1 mRNA CTD PMID:22321834 mono(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of CTNNB1 protein], mono-(2-ethylhexyl)phthalate results in increased expression of and affects the localization of CTNNB1 protein CTD PMID:29940330 Monobutylphthalate affects expression EXP 6480464 monobutyl phthalate affects the expression of CTNNB1 mRNA CTD PMID:20864626 monocrotaline multiple interactions EXP 6480464 Fluoxetine inhibits the reaction [Monocrotaline results in decreased expression of CTNNB1 protein], magnolol inhibits the reaction [Monocrotaline results in increased expression of CTNNB1 protein] CTD PMID:21619414 , PMID:30466619 monocrotaline increases expression EXP 6480464 Monocrotaline results in increased expression of CTNNB1 protein CTD PMID:30466619 monocrotaline decreases expression EXP 6480464 Monocrotaline results in decreased expression of CTNNB1 protein CTD PMID:21619414 myricetin decreases expression ISO RGD:733705 6480464 myricetin results in decreased expression of CTNNB1 protein CTD PMID:22245592 myricetin multiple interactions ISO RGD:733705 6480464 [myricetin results in increased activity of SIRT1 protein] which results in decreased expression of CTNNB1 protein CTD PMID:22245592 N(6),N(6)-dimethyladenine multiple interactions EXP 6480464 N(6), N(6)-dimethyladenine promotes the reaction [Cadmium Chloride results in decreased expression of CTNNB1 protein] CTD PMID:15618353 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions ISO RGD:733705 6480464 [IFNG protein co-treated with TNF protein co-treated with N more ... CTD PMID:16844947 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions ISO RGD:733705 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Lithium Chloride affects the localization of CTNNB1 protein modified form], N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Lithium Chloride affects the localization of CTNNB1 protein] CTD PMID:22493441 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions EXP 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Epinephrine results in increased phosphorylation of CTNNB1 protein], N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [GCG protein results in increased phosphorylation of CTNNB1 protein] CTD PMID:26964897 N-acetyl-L-cysteine multiple interactions ISO RGD:1550466 6480464 Acetylcysteine inhibits the reaction [TALDO1 gene mutant form results in decreased phosphorylation of CTNNB1 protein] CTD PMID:19436114 N-acetyl-L-cysteine multiple interactions ISO RGD:733705 6480464 Acetylcysteine inhibits the reaction [27-hydroxycholesterol inhibits the reaction [GSK3B protein binds to CTNNB1 protein]] more ... CTD PMID:16282376 more ... N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:733705 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Aspirin results in increased ubiquitination of CTNNB1 protein] more ... CTD PMID:14555707 more ... N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases degradation ISO RGD:733705 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased degradation of CTNNB1 protein CTD PMID:26990689 , PMID:32112862 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1550466 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde affects the phosphorylation of and affects the localization of CTNNB1 protein more ... CTD PMID:27693619 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions EXP 6480464 geraniol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CTNNB1 mRNA] CTD PMID:28428697 N-methyl-N'-nitro-N-nitrosoguanidine increases expression EXP 6480464 Methylnitronitrosoguanidine results in increased expression of CTNNB1 mRNA CTD PMID:28428697 N-methyl-N-nitrosourea increases expression ISO RGD:1550466 6480464 Methylnitrosourea results in increased expression of CTNNB1 protein CTD PMID:12096346 N-nitrosodiethylamine multiple interactions ISO RGD:1550466 6480464 [Diethylnitrosamine co-treated with Dietary Fats] results in increased expression of and results in increased phosphorylation of CTNNB1 protein more ... CTD PMID:20583210 more ... N-nitrosodiethylamine increases expression ISO RGD:1550466 6480464 Diethylnitrosamine results in increased expression of CTNNB1 mRNA, Diethylnitrosamine results in increased expression of CTNNB1 protein CTD PMID:20583210 , PMID:27058323 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of CTNNB1 mRNA CTD PMID:21554863 N-nitrosodiethylamine affects localization EXP 6480464 Diethylnitrosamine affects the localization of CTNNB1 protein modified form CTD PMID:21554863 N-nitrosodiethylamine multiple interactions EXP 6480464 5 more ... CTD PMID:21554863 N-nitrosodiethylamine increases mutagenesis EXP 6480464 Diethylnitrosamine results in increased mutagenesis of CTNNB1 CTD PMID:10463579 N-nitrosodiethylamine decreases response to substance ISO RGD:1550466 6480464 CTNNB1 protein results in decreased susceptibility to Diethylnitrosamine CTD PMID:20583210 N-tosyl-L-phenylalanyl chloromethyl ketone multiple interactions ISO RGD:733705 6480464 Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Nitroglycerin inhibits the reaction [CTNNB1 protein binds to TCF4 protein]] more ... CTD PMID:17030184 naproxen multiple interactions EXP 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CTNNB1 protein], Naproxen inhibits the reaction [Capsaicin results in increased expression of CTNNB1 protein] CTD PMID:22150557 naringin increases expression ISO RGD:733705 6480464 naringin results in increased expression of CTNNB1 mRNA CTD PMID:24915843 naringin multiple interactions ISO RGD:733705 6480464 naringin inhibits the reaction [Hydrogen Peroxide results in decreased expression of CTNNB1 protein] CTD PMID:26482937 niclosamide increases expression ISO RGD:733705 6480464 Niclosamide results in increased expression of CTNNB1 mRNA CTD PMID:22576131 niclosamide increases ubiquitination ISO RGD:733705 6480464 Niclosamide results in increased ubiquitination of CTNNB1 protein CTD PMID:27492973 niclosamide multiple interactions ISO RGD:733705 6480464 Imatinib Mesylate promotes the reaction [Niclosamide results in decreased expression of CTNNB1 protein] more ... CTD PMID:19772353 more ... niclosamide decreases expression ISO RGD:733705 6480464 Niclosamide analog results in decreased expression of CTNNB1 protein, Niclosamide results in decreased expression of CTNNB1 protein CTD PMID:21531761 more ... niclosamide multiple interactions EXP 6480464 Niclosamide inhibits the reaction [Epinephrine results in increased phosphorylation of CTNNB1 protein] more ... CTD PMID:26964897 , PMID:32961231 niclosamide decreases expression ISO RGD:1550466 6480464 Niclosamide results in decreased expression of CTNNB1 mRNA CTD PMID:27226553 niclosamide decreases activity ISO RGD:733705 6480464 Niclosamide results in decreased activity of CTNNB1 protein CTD PMID:25174399 nicotine multiple interactions ISO RGD:1550466 6480464 Nicotine promotes the reaction [Carbon Tetrachloride results in increased expression of CTNNB1 mRNA], Nicotine promotes the reaction [Carbon Tetrachloride results in increased expression of CTNNB1 protein] CTD PMID:33640489 nicotine increases expression ISO RGD:1550466 6480464 Nicotine results in increased expression of CTNNB1 mRNA, Nicotine results in increased expression of CTNNB1 protein CTD PMID:33640489 nimesulide affects localization ISO RGD:733705 6480464 nimesulide affects the localization of CTNNB1 protein CTD PMID:16331303 nimesulide decreases expression ISO RGD:1550466 6480464 nimesulide results in decreased expression of CTNNB1 CTD PMID:15892897 nitroglycerin multiple interactions ISO RGD:733705 6480464 4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [Nitroglycerin results in decreased localization of CTNNB1 protein] more ... CTD PMID:17030184 nitroglycerin decreases localization ISO RGD:733705 6480464 Nitroglycerin results in decreased localization of CTNNB1 protein CTD PMID:17030184 NMN zwitterion multiple interactions ISO RGD:733705 6480464 Nicotinamide Mononucleotide affects the reaction [NAMPT protein affects the expression of CTNNB1 protein], Nicotinamide Mononucleotide inhibits the reaction [N-(4-(1-benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide results in decreased expression of CTNNB1 protein] CTD PMID:32005247 O-methyleugenol increases mutagenesis ISO RGD:1550466 6480464 methyleugenol results in increased mutagenesis of CTNNB1 gene CTD PMID:10467420 ochratoxin A increases expression ISO RGD:1550466 6480464 ochratoxin A results in increased expression of CTNNB1 mRNA CTD PMID:32617660 ochratoxin A multiple interactions ISO RGD:733705 6480464 ochratoxin A results in increased expression of and affects the localization of CTNNB1 protein CTD PMID:32617660 ochratoxin A multiple interactions ISO RGD:1550466 6480464 ochratoxin A results in increased expression of and affects the localization of CTNNB1 protein CTD PMID:32617660 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of CTNNB1 protein CTD PMID:31369848 ochratoxin A increases expression ISO RGD:733705 6480464 ochratoxin A metabolite results in increased expression of CTNNB1 mRNA, ochratoxin A results in increased expression of CTNNB1 mRNA CTD PMID:26314263 , PMID:32617660 okadaic acid increases phosphorylation ISO RGD:733705 6480464 Okadaic Acid results in increased phosphorylation of CTNNB1 protein CTD PMID:16878161 okadaic acid increases expression ISO RGD:733705 6480464 Okadaic Acid results in increased expression of CTNNB1 mRNA CTD PMID:31115591 okadaic acid multiple interactions ISO RGD:733705 6480464 Okadaic Acid promotes the reaction [CTNNB1 protein binds to CDH1 protein] more ... CTD PMID:31115591 olanzapine decreases expression ISO RGD:1550466 6480464 olanzapine results in decreased expression of CTNNB1 mRNA CTD PMID:18797397 olanzapine increases expression ISO RGD:733705 6480464 Olanzapine results in increased expression of CTNNB1 mRNA CTD PMID:31563592 olanzapine multiple interactions ISO RGD:733705 6480464 Olanzapine inhibits the reaction [Dizocilpine Maleate results in decreased expression of CTNNB1 mRNA] CTD PMID:31563592 Ophiopogonin D multiple interactions ISO RGD:733705 6480464 ITGB1 protein inhibits the reaction [ophiopogonin D inhibits the reaction [TGFB1 protein results in increased expression of and affects the localization of CTNNB1 protein]], ophiopogonin D inhibits the reaction [TGFB1 protein results in increased expression of and affects the localization of CTNNB1 protein] CTD PMID:32818624 oxazepam increases mutagenesis ISO RGD:1550466 6480464 Oxazepam results in increased mutagenesis of CTNNB1 gene CTD PMID:10467420 ozone multiple interactions ISO RGD:733705 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of and affects the oxidation of CTNNB1 mRNA more ... CTD PMID:32699268 p-menthan-3-ol decreases expression ISO RGD:733705 6480464 Menthol results in decreased expression of CTNNB1 mRNA CTD PMID:26760959 paclitaxel decreases phosphorylation ISO RGD:733705 6480464 Paclitaxel results in decreased phosphorylation of CTNNB1 protein CTD PMID:23956100 paclitaxel multiple interactions ISO RGD:733705 6480464 [Oxygen deficiency co-treated with Paclitaxel co-treated with FV-429 compound co-treated with Deferoxamine] affects the localization of CTNNB1 protein, [Paclitaxel co-treated with FV-429 compound] inhibits the reaction [Oxygen deficiency results in increased expression of CTNNB1 protein] CTD PMID:34648812 paclitaxel decreases response to substance ISO RGD:733705 6480464 CTNNB1 results in decreased susceptibility to Paclitaxel CTD PMID:22000491 palbociclib multiple interactions ISO RGD:733705 6480464 2-(5-benzo(1, 3)dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochloride inhibits the reaction [palbociclib results in increased expression of CTNNB1 protein] CTD PMID:22869556 palbociclib increases expression ISO RGD:733705 6480464 palbociclib results in increased expression of CTNNB1 protein CTD PMID:22869556 paracetamol affects expression ISO RGD:1550466 6480464 Acetaminophen affects the expression of CTNNB1 mRNA CTD PMID:17562736 , PMID:19679878 paracetamol multiple interactions ISO RGD:733705 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CTNNB1 mRNA more ... CTD PMID:30567741 , PMID:33819548 paracetamol affects localization ISO RGD:733705 6480464 Acetaminophen affects the localization of CTNNB1 protein CTD PMID:30567741 paracetamol decreases expression ISO RGD:733705 6480464 Acetaminophen results in decreased expression of CTNNB1 mRNA CTD PMID:27761495 paracetamol increases expression ISO RGD:733705 6480464 Acetaminophen results in increased expression of CTNNB1 mRNA CTD PMID:21420995 paracetamol increases response to substance ISO RGD:1550466 6480464 CTNNB1 mutant form results in increased susceptibility to Acetaminophen CTD PMID:19679878 paracetamol multiple interactions ISO RGD:1550466 6480464 Acetaminophen affects the phosphorylation of and affects the localization of CTNNB1 protein more ... CTD PMID:19679878 more ... paracetamol affects localization ISO RGD:1550466 6480464 Acetaminophen affects the localization of CTNNB1 protein CTD PMID:19679878 paraquat multiple interactions ISO RGD:1550466 6480464 CTNNB1 protein inhibits the reaction [Paraquat results in increased abundance of Reactive Oxygen Species] more ... CTD PMID:23620592 more ... paraquat increases expression ISO RGD:1550466 6480464 Paraquat results in increased expression of CTNNB1 mRNA, Paraquat results in increased expression of CTNNB1 protein CTD PMID:32462952 paraquat increases expression EXP 6480464 Paraquat results in increased expression of CTNNB1 protein CTD PMID:30726711 paraquat multiple interactions EXP 6480464 Febuxostat inhibits the reaction [Paraquat results in increased expression of CTNNB1 protein] CTD PMID:30726711 paraquat multiple interactions ISO RGD:733705 6480464 LGK974 inhibits the reaction [Paraquat affects the localization of CTNNB1 protein] more ... CTD PMID:30171970 , PMID:30205152 paraquat decreases expression ISO RGD:1550466 6480464 Paraquat results in decreased expression of CTNNB1 mRNA, Paraquat results in decreased expression of CTNNB1 protein CTD PMID:27788593 , PMID:30171970 paraquat affects localization ISO RGD:733705 6480464 Paraquat affects the localization of CTNNB1 protein CTD PMID:30205152 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of CTNNB1 mRNA CTD PMID:26887261 paraquat decreases response to substance ISO RGD:1550466 6480464 CTNNB1 protein results in decreased susceptibility to Paraquat CTD PMID:23620592 parathion multiple interactions ISO RGD:733705 6480464 Atropine inhibits the reaction [Parathion results in increased expression of CTNNB1 protein mutant form], Atropine inhibits the reaction [Parathion results in increased expression of CTNNB1 protein] CTD PMID:17390078 parathion increases expression ISO RGD:733705 6480464 Parathion results in increased expression of CTNNB1 protein CTD PMID:17390078 perfluorooctane-1-sulfonic acid affects expression ISO RGD:733705 6480464 perfluorooctane sulfonic acid affects the expression of CTNNB1 mRNA CTD PMID:30738844 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:733705 6480464 perfluorooctane sulfonic acid results in decreased expression of CTNNB1 mRNA CTD PMID:32790152 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1550466 6480464 perfluorooctane sulfonic acid results in decreased expression of CTNNB1 protein CTD PMID:27018151 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1550466 6480464 Lithium Chloride inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of CTNNB1 protein] CTD PMID:27018151 perfluorooctanoic acid decreases expression ISO RGD:733705 6480464 perfluorooctanoic acid results in decreased expression of CTNNB1 mRNA, perfluorooctanoic acid results in decreased expression of CTNNB1 protein CTD PMID:23978332 , PMID:32790152 perfluorooctanoic acid decreases expression ISO RGD:1550466 6480464 perfluorooctanoic acid results in decreased expression of CTNNB1 protein CTD PMID:25743374 perfluorooctanoic acid multiple interactions ISO RGD:733705 6480464 [MK-886 binds to and results in decreased activity of PPARA protein] inhibits the reaction [perfluorooctanoic acid results in decreased expression of CTNNB1 protein] CTD PMID:23978332 pevonedistat increases abundance ISO RGD:1550466 6480464 pevonedistat results in increased abundance of CTNNB1 protein CTD PMID:22110742 pevonedistat multiple interactions ISO RGD:1550466 6480464 pevonedistat inhibits the reaction [Cisplatin results in decreased expression of CTNNB1 mRNA] CTD PMID:34476871 phenethyl caffeate decreases expression ISO RGD:1550466 6480464 caffeic acid phenethyl ester results in decreased expression of CTNNB1 protein CTD PMID:10783313 phenobarbital affects response to substance ISO RGD:1550466 6480464 CTNNB1 protein affects the susceptibility to Phenobarbital CTD PMID:21705713 phenobarbital increases expression ISO RGD:1550466 6480464 Phenobarbital results in increased expression of CTNNB1 protein alternative form CTD PMID:31836555 phenobarbital increases mutagenesis ISO RGD:1550466 6480464 Phenobarbital results in increased mutagenesis of CTNNB1 exon more ... CTD PMID:11753661 more ... phenobarbital multiple interactions ISO RGD:1550466 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased mutagenesis of CTNNB1 gene more ... CTD PMID:12384525 more ... phenol red multiple interactions ISO RGD:733705 6480464 [Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of CTNNB1 protein CTD PMID:31629898 phenylephrine multiple interactions EXP 6480464 Phenylephrine promotes the reaction [CTNNB1 protein binds to NPPA promoter] CTD PMID:19799869 phenylmercury acetate increases expression ISO RGD:733705 6480464 Phenylmercuric Acetate results in increased expression of CTNNB1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:733705 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CTNNB1 mRNA CTD PMID:27188386 PhIP multiple interactions EXP 6480464 [2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:11756241 more ... PhIP multiple interactions ISO RGD:1550466 6480464 [2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:15459021 , PMID:27664423 PhIP increases mutagenesis EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased mutagenesis of CTNNB1 gene CTD PMID:10965019 more ... PhIP increases expression ISO RGD:1550466 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of CTNNB1 protein CTD PMID:21081470 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:14507667 , PMID:23466459 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:733705 6480464 Tetradecanoylphorbol Acetate inhibits the reaction [CDH5 protein binds to CTNNB1 protein] CTD PMID:24211779 pinosylvin multiple interactions ISO RGD:733705 6480464 [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of BIRC5 mRNA more ... CTD PMID:23333577 pioglitazone multiple interactions ISO RGD:733705 6480464 [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA CTD PMID:20847119 piperine multiple interactions ISO RGD:733705 6480464 [piperine co-treated with Curcumin] results in decreased expression of CTNNB1 protein CTD PMID:30935902 pirinixic acid multiple interactions EXP 6480464 pirinixic acid inhibits the reaction [APP protein results in decreased expression of CTNNB1 protein] more ... CTD PMID:16204253 pirinixic acid decreases expression ISO RGD:1550466 6480464 pirinixic acid results in decreased expression of CTNNB1 mRNA CTD PMID:18445702 platycodin D multiple interactions ISO RGD:1550466 6480464 CTNNB1 affects the reaction [platycodin D results in decreased expression of CEBPA protein] more ... CTD PMID:21798269 pluronic P-123 multiple interactions EXP 6480464 Poloxamer promotes the reaction [Niclosamide inhibits the reaction [Thioacetamide results in increased expression of CTNNB1 protein]] CTD PMID:32961231 Poloxamer multiple interactions EXP 6480464 Poloxamer promotes the reaction [Niclosamide inhibits the reaction [Thioacetamide results in increased expression of CTNNB1 protein]] CTD PMID:32961231 potassium iodide decreases expression EXP 6480464 Potassium Iodide results in decreased expression of CTNNB1 protein CTD PMID:32593569 pravastatin affects localization EXP 6480464 Pravastatin affects the localization of CTNNB1 protein CTD PMID:17188708 pravastatin multiple interactions EXP 6480464 [resveratrol co-treated with Pravastatin] affects the localization of CTNNB1 protein CTD PMID:17188708 progesterone increases expression EXP 6480464 Progesterone results in increased expression of CTNNB1 protein CTD PMID:17170212 progesterone decreases abundance ISO RGD:1550466 6480464 CTNNB1 protein results in decreased abundance of Progesterone CTD PMID:20610534 progesterone increases response to substance ISO RGD:1550466 6480464 CTNNB1 protein results in increased susceptibility to Progesterone CTD PMID:22958837 prostaglandin E2 increases localization ISO RGD:733705 6480464 Dinoprostone results in increased localization of CTNNB1 protein CTD PMID:18395713 prostaglandin E2 increases expression ISO RGD:733705 6480464 Dinoprostone results in increased expression of CTNNB1 protein CTD PMID:30208247 prostaglandin E2 multiple interactions ISO RGD:733705 6480464 cryptotanshinone inhibits the reaction [Dinoprostone results in increased expression of CTNNB1 protein] CTD PMID:30208247 puromycin affects localization ISO RGD:1550466 6480464 Puromycin affects the localization of CTNNB1 protein CTD PMID:15673299 pyocyanine increases expression ISO RGD:1550466 6480464 Pyocyanine results in increased expression of CTNNB1 mRNA CTD PMID:31078726 pyrithione multiple interactions EXP 6480464 [Zinc co-treated with pyrithione] results in increased cleavage of CTNNB1 protein CTD PMID:17098228 quercetin decreases expression ISO RGD:733705 6480464 Quercetin results in decreased expression of CTNNB1 mRNA, Quercetin results in decreased expression of CTNNB1 protein CTD PMID:20596804 more ... quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of CTNNB1 mRNA, Quercetin results in decreased expression of CTNNB1 protein CTD PMID:20501703 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Warfarin results in increased expression of and affects the localization of CTNNB1 protein] more ... CTD PMID:20501703 , PMID:23117658 quercetin multiple interactions ISO RGD:733705 6480464 [Quercetin results in increased activity of SIRT1 protein] which results in decreased expression of CTNNB1 protein more ... CTD PMID:15670774 more ... quercetin decreases activity ISO RGD:733705 6480464 Quercetin results in decreased activity of CTNNB1 protein CTD PMID:15670774 , PMID:19440933 quercetin affects expression ISO RGD:733705 6480464 Quercetin affects the expression of CTNNB1 protein CTD PMID:15670774 quercetin 3-O-beta-D-glucofuranoside affects expression ISO RGD:733705 6480464 isoquercitrin affects the expression of CTNNB1 mRNA CTD PMID:30597948 quercetin 3-O-beta-D-glucopyranoside affects expression ISO RGD:733705 6480464 isoquercitrin affects the expression of CTNNB1 mRNA CTD PMID:30597948 quinacrine multiple interactions ISO RGD:733705 6480464 GSK3B protein affects the reaction [Quinacrine results in decreased expression of CTNNB1 protein] CTD PMID:28720477 quinacrine decreases expression ISO RGD:733705 6480464 Quinacrine results in decreased expression of CTNNB1 protein CTD PMID:28720477 rac-lactic acid increases expression ISO RGD:733705 6480464 Lactic Acid results in increased expression of CTNNB1 mRNA CTD PMID:30851411 radon atom increases expression ISO RGD:733705 6480464 Radon results in increased expression of CTNNB1 protein CTD PMID:32949624 radon(0) increases expression ISO RGD:733705 6480464 Radon results in increased expression of CTNNB1 protein CTD PMID:32949624 reactive oxygen species multiple interactions ISO RGD:1550466 6480464 CTNNB1 protein inhibits the reaction [Paraquat results in increased abundance of Reactive Oxygen Species] CTD PMID:23620592 resveratrol affects localization EXP 6480464 resveratrol affects the localization of CTNNB1 protein CTD PMID:17188708 resveratrol affects localization ISO RGD:733705 6480464 resveratrol affects the localization of CTNNB1 protein CTD PMID:22314268 more ... resveratrol increases degradation ISO RGD:733705 6480464 resveratrol results in increased degradation of CTNNB1 protein CTD PMID:26040106 resveratrol decreases expression ISO RGD:733705 6480464 resveratrol results in decreased expression of CTNNB1 mRNA, resveratrol results in decreased expression of CTNNB1 protein CTD PMID:11895924 more ... resveratrol affects localization ISO RGD:1550466 6480464 resveratrol affects the localization of CTNNB1 protein CTD PMID:19665018 resveratrol multiple interactions ISO RGD:1550466 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased stability of CTNNB1 protein] more ... CTD PMID:20542495 more ... resveratrol increases activity ISO RGD:1550466 6480464 resveratrol results in increased activity of CTNNB1 protein CTD PMID:19665018 resveratrol increases stability ISO RGD:1550466 6480464 resveratrol results in increased stability of CTNNB1 protein CTD PMID:19665018 , PMID:20542495 resveratrol multiple interactions ISO RGD:733705 6480464 [[Resveratrol results in increased activity of SIRT1 protein] promotes the reaction [SIRT1 protein binds to and results in decreased activity of EP300 protein]] which results in decreased acetylation of and results in decreased activity of CTNNB1 protein more ... CTD PMID:19047049 more ... resveratrol increases expression EXP 6480464 resveratrol results in increased expression of CTNNB1 mRNA CTD PMID:23848300 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Pravastatin] affects the localization of CTNNB1 protein CTD PMID:17188708 riboflavin increases expression ISO RGD:1550466 6480464 Riboflavin analog results in increased expression of CTNNB1 protein CTD PMID:20688149 risperidone multiple interactions EXP 6480464 DRD2 protein affects the reaction [Risperidone results in increased expression of CTNNB1 protein] CTD PMID:16144542 risperidone increases expression EXP 6480464 Risperidone results in increased expression of CTNNB1 protein CTD PMID:16144542 rotenone multiple interactions EXP 6480464 Lithium Chloride inhibits the reaction [Rotenone results in decreased expression of and results in decreased phosphorylation of CTNNB1 protein], Rotenone results in decreased expression of and results in decreased phosphorylation of CTNNB1 protein CTD PMID:27045591 Salinomycin multiple interactions ISO RGD:733705 6480464 salinomycin inhibits the reaction [TGFB1 protein results in increased expression of and results in increased activity of CTNNB1 mRNA] CTD PMID:26896736 SB 203580 multiple interactions ISO RGD:733705 6480464 [Cannabidiol co-treated with SB 203580] results in decreased phosphorylation of CTNNB1 protein more ... CTD PMID:19814765 , PMID:32060308 SB 203580 decreases phosphorylation ISO RGD:733705 6480464 SB 203580 results in decreased phosphorylation of CTNNB1 protein CTD PMID:32060308 SB 415286 multiple interactions ISO RGD:1550466 6480464 [3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2, 5-dione results in decreased activity of GSK3B protein] which results in increased expression of CTNNB1 protein CTD PMID:19159680 SB 431542 multiple interactions ISO RGD:733705 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 serpentine asbestos decreases expression ISO RGD:733705 6480464 Asbestos more ... CTD PMID:26685284 , PMID:30609805 serpentine asbestos multiple interactions ISO RGD:733705 6480464 Asbestos more ... CTD PMID:24160326 , PMID:26685284 silicon dioxide increases expression ISO RGD:1550466 6480464 Silicon Dioxide results in increased expression of CTNNB1 mRNA, Silicon Dioxide results in increased expression of CTNNB1 protein CTD PMID:29203145 , PMID:29216763 silicon dioxide multiple interactions ISO RGD:1550466 6480464 MIR23C mRNA inhibits the reaction [Silicon Dioxide results in increased expression of CTNNB1 mRNA], MIR23C mRNA inhibits the reaction [Silicon Dioxide results in increased expression of CTNNB1 protein] CTD PMID:29216763 simvastatin multiple interactions ISO RGD:1550466 6480464 CTNNB1 mutant form inhibits the reaction [Simvastatin results in increased expression of BGLAP protein], CTNNB1 mutant form inhibits the reaction [Simvastatin results in increased expression of SP7 protein] CTD PMID:22058016 simvastatin increases expression EXP 6480464 Simvastatin results in increased expression of CTNNB1 protein CTD PMID:18004065 simvastatin increases expression ISO RGD:1550466 6480464 Simvastatin results in increased expression of CTNNB1 protein CTD PMID:22058016 simvastatin multiple interactions EXP 6480464 Simvastatin inhibits the reaction [Glucose results in decreased expression of CTNNB1 protein] CTD PMID:18004065 sirolimus multiple interactions EXP 6480464 Sirolimus promotes the reaction [Dibutyl Phthalate results in increased expression of CTNNB1 mRNA] CTD PMID:30053495 sodium arsenate decreases expression EXP 6480464 sodium arsenate results in decreased expression of CTNNB1 mRNA, sodium arsenate results in decreased expression of CTNNB1 protein CTD PMID:14713550 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of CTNNB1 mRNA CTD PMID:23137061 sodium arsenite affects localization ISO RGD:733705 6480464 sodium arsenite affects the localization of CTNNB1 protein CTD PMID:22859221 sodium arsenite increases expression ISO RGD:1550466 6480464 sodium arsenite results in increased expression of CTNNB1 mRNA CTD PMID:25825268 sodium arsenite decreases expression ISO RGD:1550466 6480464 sodium arsenite results in decreased expression of CTNNB1 mRNA more ... CTD PMID:23143138 more ... sodium arsenite affects expression ISO RGD:1550466 6480464 sodium arsenite affects the expression of CTNNB1 mRNA CTD PMID:16507464 , PMID:28206643 sodium arsenite multiple interactions ISO RGD:1550466 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [sodium arsenite results in decreased expression of CTNNB1 protein], [Folic Acid co-treated with sodium arsenite] results in increased methylation of CTNNB1 mRNA CTD PMID:22959928 , PMID:23143138 sodium arsenite increases expression ISO RGD:733705 6480464 sodium arsenite results in increased expression of CTNNB1 protein CTD PMID:16054901 more ... sodium arsenite decreases expression ISO RGD:733705 6480464 sodium arsenite results in decreased expression of CTNNB1 protein CTD PMID:23219847 more ... sodium arsenite multiple interactions ISO RGD:733705 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite affects the localization of CTNNB1 protein] more ... CTD PMID:22859221 more ... sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of CTNNB1 mRNA CTD PMID:24300170 sodium fluoride multiple interactions ISO RGD:733705 6480464 Sodium Fluoride promotes the reaction [CTNNB1 protein binds to CCND1 promoter] CTD PMID:33982124 sodium fluoride affects localization ISO RGD:733705 6480464 Sodium Fluoride affects the localization of CTNNB1 protein CTD PMID:33982124 sodium fluoride increases expression ISO RGD:1550466 6480464 Sodium Fluoride results in increased expression of CTNNB1 mRNA, Sodium Fluoride results in increased expression of CTNNB1 protein CTD PMID:29447955 sodium fluoride multiple interactions ISO RGD:1550466 6480464 [Sodium Fluoride results in increased susceptibility to PTH protein] which results in increased expression of CTNNB1 mRNA more ... CTD PMID:29447955 , PMID:35218729 sodium fluoride decreases expression ISO RGD:1550466 6480464 Sodium Fluoride results in decreased expression of CTNNB1 protein CTD PMID:28918527 sodium fluoride multiple interactions EXP 6480464 Sodium Fluoride results in increased expression of and affects the localization of CTNNB1 protein CTD PMID:24300170 sodium sulfide (anhydrous) multiple interactions ISO RGD:1550466 6480464 [Hydrogen Sulfide results in increased abundance of sodium sulfide] which results in decreased expression of CTNNB1 mRNA more ... CTD PMID:33068716 sorafenib multiple interactions ISO RGD:733705 6480464 sorafenib promotes the reaction [destruxin B results in decreased expression of CTNNB1 protein] CTD PMID:24434019 sporidesmin A affects localization ISO RGD:733705 6480464 sporidesmin affects the localization of CTNNB1 protein CTD PMID:28193462 staurosporine increases phosphorylation EXP 6480464 Staurosporine results in increased phosphorylation of CTNNB1 protein CTD PMID:19741129 streptozocin multiple interactions ISO RGD:1550466 6480464 5-Methoxypsoralen inhibits the reaction [Streptozocin results in increased phosphorylation of CTNNB1 protein], Tadalafil inhibits the reaction [Streptozocin results in increased phosphorylation of CTNNB1 protein] CTD PMID:34428446 streptozocin increases phosphorylation ISO RGD:1550466 6480464 Streptozocin results in increased phosphorylation of CTNNB1 protein CTD PMID:34428446 SU6656 affects localization ISO RGD:733705 6480464 SU 6656 affects the localization of CTNNB1 protein CTD PMID:23527294 sulfasalazine multiple interactions ISO RGD:1550466 6480464 [[Sulfasalazine results in decreased activity of SLC7A11 protein] which results in decreased localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of CCND1 mRNA, [Sulfasalazine results in decreased activity of SLC7A11 protein] which results in decreased localization of and results in decreased activity of CTNNB1 protein CTD PMID:19015640 sulfasalazine multiple interactions EXP 6480464 Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CTNNB1 mRNA], Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CTNNB1 protein] CTD PMID:26165751 sulindac multiple interactions ISO RGD:733705 6480464 CTNNB1 protein affects the reaction [Sulindac results in decreased expression of CCND1 protein] more ... CTD PMID:11751639 , PMID:18291362 sulindac multiple interactions EXP 6480464 epigallocatechin gallate promotes the reaction [Sulindac inhibits the reaction [1 more ... CTD PMID:29999212 sulindac decreases expression ISO RGD:1550466 6480464 Sulindac results in decreased expression of CTNNB1 protein CTD PMID:10223192 sulindac multiple interactions ISO RGD:1550466 6480464 [Sulindac co-treated with Plant Extracts] results in decreased expression of CTNNB1 protein CTD PMID:12351151 sulindac decreases expression ISO RGD:733705 6480464 Sulindac results in decreased expression of CTNNB1 protein CTD PMID:18291362 sulindac sulfide multiple interactions ISO RGD:733705 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sulindac sulfide results in decreased expression of CTNNB1 protein] more ... CTD PMID:14555707 more ... sulindac sulfide decreases expression ISO RGD:733705 6480464 sulindac sulfide results in decreased expression of CTNNB1 protein CTD PMID:14555707 sulindac sulfone increases expression ISO RGD:733705 6480464 sulindac sulfone results in increased expression of CTNNB1 protein CTD PMID:11602670 sulindac sulfone decreases expression ISO RGD:733705 6480464 sulindac sulfone results in decreased expression of CTNNB1 protein CTD PMID:10910034 more ... sulindac sulfone multiple interactions ISO RGD:733705 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sulindac sulfone results in decreased expression of CTNNB1 protein] CTD PMID:14555707 sumatriptan multiple interactions EXP 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CTNNB1 protein], Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CTNNB1 protein] CTD PMID:22150557 sunitinib increases expression ISO RGD:733705 6480464 sunitinib results in increased expression of CTNNB1 mRNA CTD PMID:25605917 tadalafil multiple interactions ISO RGD:1550466 6480464 Tadalafil inhibits the reaction [Streptozocin results in increased phosphorylation of CTNNB1 protein] CTD PMID:34428446 tamoxifen multiple interactions ISO RGD:733705 6480464 3 more ... CTD PMID:22046442 , PMID:23921149 tamoxifen decreases expression ISO RGD:733705 6480464 Tamoxifen results in decreased expression of CTNNB1 protein CTD PMID:23921149 Tanshinone I increases expression ISO RGD:1550466 6480464 tanshinone results in increased expression of CTNNB1 mRNA CTD PMID:25186638 Tanshinone I multiple interactions ISO RGD:733705 6480464 [Doxorubicin co-treated with tanshinone] results in decreased expression of CTNNB1 protein CTD PMID:32886829 temozolomide multiple interactions ISO RGD:1550466 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Temozolomide results in decreased phosphorylation of CTNNB1 protein] CTD PMID:31758290 temozolomide decreases phosphorylation ISO RGD:1550466 6480464 Temozolomide results in decreased phosphorylation of CTNNB1 protein CTD PMID:31758290 temozolomide multiple interactions ISO RGD:733705 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Temozolomide results in decreased phosphorylation of CTNNB1 protein], Temozolomide results in decreased phosphorylation of and affects the localization of CTNNB1 protein CTD PMID:31758290 tert-butyl hydroperoxide multiple interactions ISO RGD:733705 6480464 [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA more ... CTD PMID:20847119 tert-butyl hydroperoxide increases expression ISO RGD:733705 6480464 tert-Butylhydroperoxide results in increased expression of CTNNB1 mRNA CTD PMID:20847119 testosterone increases expression ISO RGD:733705 6480464 Testosterone results in increased expression of CTNNB1 protein CTD PMID:21468052 testosterone multiple interactions ISO RGD:733705 6480464 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3 more ... CTD PMID:28163245 testosterone decreases phosphorylation ISO RGD:733705 6480464 Testosterone results in decreased phosphorylation of CTNNB1 protein CTD PMID:28163245 testosterone increases expression ISO RGD:1550466 6480464 Testosterone results in increased expression of CTNNB1 protein CTD PMID:21468052 tetrachloromethane multiple interactions ISO RGD:1550466 6480464 NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of CTNNB1 protein]] more ... CTD PMID:27477297 , PMID:33640489 tetrachloromethane increases expression ISO RGD:1550466 6480464 Carbon Tetrachloride results in increased expression of CTNNB1 mRNA, Carbon Tetrachloride results in increased expression of CTNNB1 protein CTD PMID:27477297 more ... tetramethylpyrazine decreases expression ISO RGD:733705 6480464 tetramethylpyrazine results in decreased expression of CTNNB1 mRNA, tetramethylpyrazine results in decreased expression of CTNNB1 protein CTD PMID:27477297 tetramethylpyrazine multiple interactions ISO RGD:733705 6480464 NFE2L2 protein promotes the reaction [tetramethylpyrazine results in decreased expression of CTNNB1 mRNA] more ... CTD PMID:24961358 , PMID:27477297 tetramethylpyrazine multiple interactions ISO RGD:1550466 6480464 NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of CTNNB1 protein]], tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of CTNNB1 protein] CTD PMID:27477297 theaflavin multiple interactions ISO RGD:1550466 6480464 theaflavin inhibits the reaction [Diethylnitrosamine results in increased expression of CTNNB1 mRNA], theaflavin inhibits the reaction [Diethylnitrosamine results in increased expression of CTNNB1 protein] CTD PMID:27058323 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CTNNB1 protein CTD PMID:32961231 thioacetamide multiple interactions EXP 6480464 Niclosamide inhibits the reaction [Thioacetamide results in increased expression of CTNNB1 protein], Poloxamer promotes the reaction [Niclosamide inhibits the reaction [Thioacetamide results in increased expression of CTNNB1 protein]] CTD PMID:32961231 thymoquinone decreases expression ISO RGD:1550466 6480464 thymoquinone results in decreased expression of CTNNB1 protein CTD PMID:32112862 thymoquinone multiple interactions ISO RGD:733705 6480464 CTNNB1 protein inhibits the reaction [thymoquinone results in decreased expression of CDH2 protein] more ... CTD PMID:32112862 thymoquinone decreases expression ISO RGD:733705 6480464 thymoquinone results in decreased expression of CTNNB1 mRNA CTD PMID:32112862 titanium dioxide affects expression ISO RGD:1550466 6480464 titanium dioxide affects the expression of CTNNB1 mRNA CTD PMID:17656681 toluene 2,4-diisocyanate increases phosphorylation ISO RGD:1550466 6480464 Toluene 2, 4-Diisocyanate results in increased phosphorylation of CTNNB1 protein CTD PMID:26089345 toluene 2,4-diisocyanate affects localization ISO RGD:733705 6480464 Toluene 2, 4-Diisocyanate analog affects the localization of CTNNB1 protein CTD PMID:30261222 toluene 2,4-diisocyanate affects localization ISO RGD:1550466 6480464 Toluene 2, 4-Diisocyanate affects the localization of CTNNB1 protein CTD PMID:30261222 toluene 2,4-diisocyanate multiple interactions ISO RGD:733705 6480464 AG 1879 inhibits the reaction [Toluene 2 more ... CTD PMID:30261222 toluene 2,4-diisocyanate multiple interactions ISO RGD:1550466 6480464 2-(1 more ... CTD PMID:26089345 more ... topotecan multiple interactions ISO RGD:733705 6480464 acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Topotecan results in increased cleavage of CTNNB1 protein], chrysin inhibits the reaction [Topotecan results in increased cleavage of CTNNB1 protein] CTD PMID:20457140 topotecan increases cleavage ISO RGD:733705 6480464 Topotecan results in increased cleavage of CTNNB1 protein CTD PMID:20457140 trans-pinosylvin multiple interactions ISO RGD:733705 6480464 [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of BIRC5 mRNA more ... CTD PMID:23333577 tremolite asbestos multiple interactions ISO RGD:733705 6480464 tremolite results in decreased expression of and affects the localization of CTNNB1 protein CTD PMID:22578742 tributylstannane increases expression ISO RGD:733705 6480464 tributyltin results in increased expression of CTNNB1 mRNA CTD PMID:26314263 Tributyltin oxide increases expression ISO RGD:733705 6480464 bis(tri-n-butyltin)oxide results in increased expression of CTNNB1 mRNA CTD PMID:26314263 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of CTNNB1 mRNA CTD PMID:14565619 trichostatin A multiple interactions ISO RGD:733705 6480464 [3-deazaneplanocin co-treated with trichostatin A] affects the expression of CTNNB1 protein more ... CTD PMID:18538736 more ... trichostatin A increases expression ISO RGD:733705 6480464 trichostatin A results in increased expression of CTNNB1 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1550466 6480464 [estradiol dipropionate co-treated with trichostatin A] results in decreased expression of CTNNB1 protein CTD PMID:15930180 triptonide affects expression ISO RGD:1550466 6480464 triptonide affects the expression of CTNNB1 mRNA CTD PMID:33045310 troglitazone multiple interactions ISO RGD:733705 6480464 [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA, troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CTNNB1 mRNA] CTD PMID:20847119 troglitazone decreases expression ISO RGD:1550466 6480464 troglitazone results in decreased expression of CTNNB1 CTD PMID:15892897 tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate multiple interactions ISO RGD:733705 6480464 Atropine inhibits the reaction [Parathion results in increased expression of CTNNB1 protein mutant form], Atropine inhibits the reaction [Parathion results in increased expression of CTNNB1 protein] CTD PMID:17390078 tyrphostin AG 1478 multiple interactions ISO RGD:733705 6480464 RTKI cpd inhibits the reaction [arsenite affects the localization of CTNNB1 protein] CTD PMID:17400267 tyrphostin AG 1478 decreases expression ISO RGD:733705 6480464 RTKI cpd results in decreased expression of CTNNB1 protein CTD PMID:29974605 uranium atom decreases expression EXP 6480464 Uranium analog results in decreased expression of CTNNB1 mRNA CTD PMID:27544493 ursolic acid multiple interactions ISO RGD:733705 6480464 ursolic acid results in increased phosphorylation of and results in increased degradation of CTNNB1 protein CTD PMID:24566423 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of CTNNB1 protein CTD PMID:12942141 , PMID:20734317 valproic acid multiple interactions ISO RGD:733705 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CTNNB1 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:733705 6480464 Valproic Acid results in increased expression of CTNNB1 mRNA CTD PMID:24383497 more ... valproic acid affects expression ISO RGD:733705 6480464 Valproic Acid affects the expression of CTNNB1 mRNA CTD PMID:23179753 venlafaxine hydrochloride increases expression EXP 6480464 Venlafaxine Hydrochloride results in increased expression of CTNNB1 protein CTD PMID:18511088 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of CTNNB1 mRNA CTD PMID:19015723 vincristine increases expression ISO RGD:733705 6480464 Vincristine results in increased expression of CTNNB1 mRNA CTD PMID:23649840 vincristine decreases response to substance ISO RGD:733705 6480464 CTNNB1 results in decreased susceptibility to Vincristine CTD PMID:22000491 vinyl carbamate increases mutagenesis ISO RGD:1550466 6480464 vinyl carbamate results in increased mutagenesis of CTNNB1 gene CTD PMID:10467420 vitamin E multiple interactions ISO RGD:733705 6480464 Vitamin E inhibits the reaction [Curcumin results in decreased expression of CTNNB1 protein] CTD PMID:30935902 vitamin E multiple interactions EXP 6480464 [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of and affects the localization of CTNNB1 protein], [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of CTNNB1 protein] CTD PMID:29940330 vorinostat multiple interactions ISO RGD:733705 6480464 vorinostat results in increased expression of and results in increased activity of CTNNB1 protein CTD PMID:17417771 warfarin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Warfarin results in increased expression of and affects the localization of CTNNB1 protein], Warfarin results in increased expression of and affects the localization of CTNNB1 protein CTD PMID:23117658 warfarin affects response to substance EXP 6480464 CTNNB1 protein affects the susceptibility to Warfarin CTD PMID:23223575 warfarin multiple interactions ISO RGD:733705 6480464 Warfarin results in decreased expression of and affects the localization of CTNNB1 protein CTD PMID:26206560 wogonin multiple interactions ISO RGD:733705 6480464 Lithium Chloride inhibits the reaction [wogonin results in decreased expression of CTNNB1 protein] CTD PMID:23872260 wogonin multiple interactions EXP 6480464 Lithium Chloride inhibits the reaction [wogonin results in decreased expression of CTNNB1 protein], wogonin inhibits the reaction [Cisplatin results in increased expression of CTNNB1 protein] CTD PMID:23872260 , PMID:31103702 wogonin increases expression ISO RGD:733705 6480464 wogonin results in increased expression of CTNNB1 protein modified form CTD PMID:23872260 wogonin decreases expression ISO RGD:733705 6480464 wogonin results in decreased expression of CTNNB1 protein CTD PMID:23872260 wogonin decreases expression EXP 6480464 wogonin results in decreased expression of CTNNB1 protein CTD PMID:23872260 wogonin increases expression EXP 6480464 wogonin results in increased expression of CTNNB1 protein modified form CTD PMID:23872260 wortmannin decreases expression ISO RGD:733705 6480464 wortmannin results in decreased expression of CTNNB1 protein CTD PMID:11739494 wortmannin multiple interactions ISO RGD:733705 6480464 wortmannin inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CTNNB1 protein] more ... CTD PMID:28163245 , PMID:28321046 wortmannin increases phosphorylation ISO RGD:733705 6480464 wortmannin results in increased phosphorylation of CTNNB1 protein CTD PMID:28163245 xanthohumol multiple interactions EXP 6480464 xanthohumol inhibits the reaction [Azoxymethane results in decreased phosphorylation of and results in increased activity of CTNNB1 protein] CTD PMID:31714664 XAV939 multiple interactions ISO RGD:733705 6480464 XAV939 inhibits the reaction [CTNNB1 protein binds to CTNNBIP1 protein] more ... CTD PMID:24534281 , PMID:32112862 XAV939 decreases expression ISO RGD:1550466 6480464 XAV939 results in decreased expression of CTNNB1 mRNA CTD PMID:27226553 XAV939 decreases expression EXP 6480464 XAV939 results in decreased expression of CTNNB1 protein CTD PMID:24231000 XAV939 multiple interactions EXP 6480464 XAV939 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CTNNB1 protein] CTD PMID:24231000 XAV939 decreases expression ISO RGD:733705 6480464 XAV939 results in decreased expression of CTNNB1 protein CTD PMID:25061499 zinc atom multiple interactions ISO RGD:733705 6480464 Zinc inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with N more ... CTD PMID:16844947 zinc atom multiple interactions EXP 6480464 [Zinc co-treated with pyrithione] results in increased cleavage of CTNNB1 protein, Zinc deficiency results in decreased activity of and results in decreased expression of CTNNB1 protein CTD PMID:17098228 , PMID:21893222 zinc(0) multiple interactions ISO RGD:733705 6480464 Zinc inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with N more ... CTD PMID:16844947 zinc(0) multiple interactions EXP 6480464 [Zinc co-treated with pyrithione] results in increased cleavage of CTNNB1 protein, Zinc deficiency results in decreased activity of and results in decreased expression of CTNNB1 protein CTD PMID:17098228 , PMID:21893222
